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ABSTRACT 
 
The entire history of HIV-1 is hidden in its ten thousand bases, where information 
regarding its evolutionary traversal through the human population can only be unlocked 
with fine-scale sequence analysis. Measureable footprints of mutation and recombination 
have imparted upon us a wealth of knowledge, from multiple chimpanzee-to-human 
transmissions to patterns of neutralizing antibody and drug resistance. Extracting 
maximum understanding from such diverse data can only be accomplished by analyzing 
the viral population from many angles. 
 This body of work explores two primary aspects of HIV sequence evolution, point 
mutation and recombination, through cross-sectional (inter-individual) and longitudinal 
(intra-individual) investigations, respectively.   
 
Cross-sectional Analysis: 
 The role of Haiti in the subtype B pandemic has been hotly debated for years; 
while there have been many studies, up to this point, no one has incorporated the well-
known mechanism of retroviral recombination into their biological model. Prior to the 
use of recombination detection, multiple analyses produced trees where subtype B 
appears to have first entered Haiti, followed by a jump into the rest of the world. The 
results presented here contest the Haiti-first theory of the pandemic and instead suggest 
simultaneous entries of subtype B into Haiti and the rest of the world. 
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Longitudinal Analysis: 
 Potential N-linked glycosylation sites (PNGS) are the most evolutionarily 
dynamic component of one of the most evolutionarily dynamic proteins known to date. 
While the number of mutations associated with the increase or decrease of PNGS 
frequency over time is high, there are a set of relatively stable sites that persist within and 
between longitudinally sampled individuals. Here, I identify the most conserved stable 
PNGSs and suggest their potential roles in host-virus interplay. In addition, I have 
identified, for the first time, what may be a gp-120-based environmental preference for 
N-linked glycosylation sites. 
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CHAPTER 1 
INSIGHTS INTO HIV EVOLUTION: AN INTRODUCTION 
 
Historical Background 
Recognition of an epidemic 
More than three decades ago, the Centers for Disease Control and Prevention (CDC) 
started publishing reports of Pneumocystis carinii, a rare opportunistic fungus, in men 
who have sex with men (MSM) living in Los Angeles (CDC 1981c). Shortly thereafter, 
reports of a rare cancer, Kaposi’s sarcoma (KS), emerged and revealed that young MSM 
on both the east and west coasts of the United States were afflicted (CDC 1981b). Two 
months later, in August of 1981, the total number of individuals diagnosed with P. carinii 
and/or KS had jumped to 111, now including heterosexual men and women as well as 
MSM (CDC 1981a). The following year, reports of rare opportunistic infections and KS 
in a total of 34 Haitians residing in Florida, New York, California, Georgia and New 
Jersey were released (CDC 1982b). Five days later, the CDC reported that three non-IV 
drug abusing heterosexual males with hemophilia A were infected with P. carinii (CDC 
1982a). Within a very short period of time, it was established that the etiologic agent 
resulting in acquired immunodeficiency syndrome (AIDS) could be transmitted sexually 
or though transfusion of blood-borne products. From these early reports, four high risk 
groups were identified: Homosexuals, Heroine addicts, Hemophiliacs and Haitians; 
collectively given the moniker, the “4 H’s” (Gallo 2006). As the validated number of 
infections grew, borders between the 4 H’s and the rest of the population diminished and 
it became evident that anyone could become infected. De Cock et al. (2011) referred to 
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these initial reports as, “sentinels for what became one of history’s worst pandemics, with 
>60 million infections, 30 million deaths, and no end in sight.” 
 
The Etiologic Agent 
In 1983, it was determined that the etiologic agent causing AIDS was a retrovirus (Barre-
Sinoussi et al. 1983), later named the Human Immunodeficiency Virus (Coffin et al. 
1986). Shortly after, a cell line was discovered that could be infected by and continually 
produce high quantities of the retrovirus for molecular characterization and detection 
purposes (Popovic et al. 1984). These findings and others that followed were referred to 
as the period of “Intense Discovery” within the rich history of AIDS (Gallo 2006). 
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Molecular Characteristics of HIV 
In early 1985, the first full-length sequence of the Human Immunodeficiency Virus was 
published with six fold coverage (Wain-Hobson et al. 1985). It was revealed that the 
retrovirus was nearly 10,000 bases in length and did include the expected polycistronic 
retroviral core genes: gag, pol and env (Fig. 1A). Specifically, after the Gag-Pol 
polyprotein is cleaved, Gag is further broken down into the structural matrix (MA), 
capsid (CA), nucleocapsid (NC) and p6 proteins. The proteins resulting from the 
proteolytic cleavage of the enzymatic Pol protein are protease (PR), reverse transcriptase 
(RT, this includes the ribonuclease H or RH region) and integrase (INT). Cleavage of the 
Env protein results in two structural proteins; the surface protein (gp120) and the 
transmembrane protein (gp41). Interestingly, Wain-Hobson et al. (1985) described two 
additional open reading frames, originally referred to as Q and F, which clearly set HIV 
apart from other identified retroviruses. Later, it was determined that HIV actually had an 
additional six accessory genes, bringing the total gene count to nine and the protein count 
to 15 (Frankel, Young 1998). 
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Figure 1. (A) HIV-1 HXB2 genome and (B) the relative evolutionary rate for each position. 
HXB2 is the HIV-1 subtype B reference sequence in the Los Alamos National Laboratories HIV 
Database (accession K03455).
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 The initiation of the HIV lifecycle occurs with the binding of the viral gp120 with 
the host T-cell CD4 receptor and is quickly followed by that same gp120 also binding to 
either the host CCR5 or CXCR4 co-receptor (Figs. 2 and 3, step 1) (Frankel, Young 
1998; Anastassopoulou 2012). This binding triggers a conformational change in gp41, 
promoting fusion of the virus and host cell, and subsequent adsorption of the viral core. 
 
Figure 2. gp120 binding to CD4 and then the coreceptor; either CCR5 or CXCR4. 
Adapted from Figure 1 in Anastassopoulou (2012). 
 
Next the retroviral RNA is reverse transcribed into cDNA (Fig. 3, step 2). (See below for 
a detailed explanation of reverse transcription). It should be noted that coat is removed 
from the viral core at some point between entry into the cellular cytoplasm and reaching 
the nucleus, although the timing of uncoating is conjectural (Arhel 2010). The new 
double stranded viral cDNA is transferred to the nucleus and will gain entry to the 
organelle through a nuclear pore (Fig. 3, step 3). Integration of the cDNA into the host 
chromosome is catalyzed by the INT protein (Fig 3, step 4). Next, host RNA polymerase 
transcribes the viral DNA into mRNA transcripts, including full-lengths and spliced 
forms, which are transported out of the nucleus and into the cytoplasm (Fig. 3, step 5). 
There, the transcripts are either packaged (full-length) or translated into viral protein 
products (Fig. 3, step 6). Specifically, the Gag and Gag-Pol polyproteins are localized to 
gp120
Cd4 Coreceptor
gp41
Host Cell
Membrane
Viral Membrane
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the cellular membrane where assembly of the viral core takes place, while Env is 
localized to the endoplasmic reticulum to undergo post-translational modifications (not 
shown). Mature Env proteins are then translocated to the cell surface where the core 
particle buds, coated in gp41/gp120 complexes. The final step in this process occurs 
during or right after budding, when the Gag-Pol polyproteins are proteolytically cleaved, 
resulting in a mature virus (Fig. 3, step 8) (Frankel, Young 1998). 
 
 
Figure 3.HIV lifecycle. Each step, as is described in the text, is numbered in blue. 
Adapted from Monini et al. (2004). 
 
Mechanisms of Variability 
Perhaps the most interesting step in the HIV lifecycle is that of reverse transcription, not 
because it completely disregards the established central dogma of transcription, but 
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because it generates immense diversity through its propensity for inaccuracy. As 
mentioned above, reverse transcription takes place shortly after entry of the viral core 
into the cellular cytoplasm (Fig. 3, step 2). The first step of reverse transcription requires 
that a tRNA is bound to the primer binding site (PBS), to act as a primer for RT (Fig. 4, 
step 1). RT synthesizes negative strand DNA through the 5’ end of the viral RNA and RH 
degrades the RNA portion of the RNA:DNA duplex. The resulting DNA is referred to as 
minus-strand strong-stop DNA (-sssDNA) (Fig. 4, step 2). The now free –sssDNA 
undergoes first strand transfer, where the repeat region (R) is annealed to the 
complimentary 3’R of the viral RNA (Fig. 4, step 3). Reverse transcription of the 
negative strand can reinitiate, while RH digests all but the polypurine tract (ppt) of the 
viral RNA strand (Fig. 4, step 4), which acts as a primer for positive strand synthesis. 
Positive strand synthesis, which uses the negative stranded DNA as a template, continues 
through a portion of the tRNA primer. Once the tRNA is in a partial duplex with DNA, 
RH can degrade the tRNA (Fig. 4, step 5). The partial positive strand DNA is referred to 
as plus-strand strong-strop DNA (+sssDNA). The second strand transfer occurs when the 
+sssDNA is transferred such that the PBS regions on the positive and negative strands are 
annealed (Fig. 4, step 6). RT completes the synthesis of the positive strand, starting at the 
PBS through the 3’ end, yielding double stranded cDNA (Fig. 4, step 7) (Coffin, Hughes, 
Varmus 1997; Hu, Hughes 2012). 
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Figure 4. Process of reverse transcription. Blue represents RNA while green represents DNA. 
The gold circle labeled RT represents the RT molecule performing reverse transcription. All 
steps are described in the text. This figure was conceptually modified from multiple sources 
(Coffin, Hughes, Varmus 1997; Hu, Hughes 2012).
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 Reverse transcriptase is notorious for its tendency to generate mutation 
throughout the described conversion of RNA to DNA (Fig. 4), with an estimated 
mutation rate between 10
-5
 and 10
-4
 (Coffin 1995), leading to approximately one mutation 
per generation. These errors generally take one of two forms: base substitutions and 
frameshift mutations. Both can be the result of insertions or deletions, while 
misincorporation can also cause base substitutions. One well-known cause of these errors 
is slippage of the two DNA strands in a repetitive region (e.g. Fig. 4, step 5, R region). 
After slippage and the addition the next base, if the strands are able to correctly realign, 
the slippage will result in misincorporation and a base substitution. Alternatively, if the 
strands never correctly realign, the result is either a single insertion in the primer strand 
or deletion in the template strand, leading to a frameshift (Bebenek, Kunkel 1993). 
 In addition to the low fidelity of reverse transcriptase, recombination is a second 
mechanism that can generate variability. Retroviral recombination occurs between two 
strands of viral genomic RNA and occurs at a rate of approximately 2.4×10
-4 
/ bp / 
generation, equivalent to 2.4 crosses per round of replication (Jetzt et al. 2000; Rhodes, 
Wargo, Hu 2003; Lanciault, Champoux 2006). While recombination likely occurs 
between identical strands, the process is only detectable between variant strands of RNA. 
Therefore, detectable recombination is initiated when two variant viruses either 
simultaneously or sequentially infect a single cell (Fig. 5). Both undergo the same 
processes explained in Fig. 3, but after each variant has undergone transcription (Fig. 3, 
step 5), it is possible, through chance alone, that a genomic RNA from each will be co-
packaged. When the bi-variant virion infects a new cell, and reverse transcription takes 
place, it is possible that during strand switching of reverse transcription (Fig. 4, steps 3 
10 
 
and 6), -sssDNA or +sssDNA will anneal to the RNA strand that it was not originally 
reverse transcribed from or the DNA it should be paired with, respectively (Goodrich, 
Duesberg 1990; Hu, Temin 1990). Recombination can have an additive fitness effect, in 
that it can combine adaptive mutations, or the reverse, where combining mutations can 
prove to lower fitness (Fisher 1930; Muller 1932). Additionally, many mutations are 
likely to be neutral, their combination having no effect on fitness. 
 The errors made during reverse transcription, whether mutation or recombination, 
would not be able to generate nearly as much population variability if it was not for the 
rapid turnover of viral replication. The generation time of a single virus is 2.6 days on 
average, from release of a virus to the infection of a new cell through the release of new 
viral progeny (Perelson et al. 1996). That translates to over 1,400 generations within a 
person infected for 10 years. Even more astonishing is that the estimated total daily 
production of 10.3×10
9
 virions per day (Perelson et al. 1996), coupled with the mutation 
rate, presents the opportunity for every possible single point mutation to occur 10,000 to 
100,000 times per day (Coffin 1995), making HIV one of the most variable genomes 
described to date. 
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Figure 5. HIV Recombination.
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While RT can produce errors anywhere along the genome, detectable errors, 
which are tolerated such that the virus is able to undergo the entire replication cycle, are 
highly concentrated in the env gene (Fig. 1B). This viral diversity was first noted (Hahn 
et al. 1985) immediately after the first research groups started sequencing whole HIV 
genomes from different isolates (Hahn et al. 1985; Ratner, Gallo, Wong-Staal 1985; 
Ratner et al. 1985; Wong-Staal et al. 1985). Further analyses revealed that not only is 
there substantial variation between viral isolates sampled from different individuals, but 
also within a single individual. Initially, comparisons were made using differences among 
restriction digestion patterns from different clones isolated from the same individual. 
These patterns differed by 11-44%, resulting in an estimated nucleotide sequence 
difference of 2-7%. Moreover, in vitro isolation and amplification did not yield the same 
type or number of changes that were seen from patient isolates, indicating that in vivo 
variation is generated rapidly (Saag et al. 1988), likely due to selective pressure exerted 
by the host immune system on the virus. 
 
Intra-individual evolution 
Within a single individual, the HIV population experiences a wide range of selective 
pressures elicited by both the cellular and humoral immune reponses. Given that the host 
immune system retains a high level of plasticity at any given time point, the HIV 
quasispecies undergoes strong episodes of diversifying selection (Lemey, Rambaut, 
Pybus 2006). Diversifying, or disruptive, selection can be classified as the favoring of 
several variants at any given moment in time. As a result, given that selection acts on the 
phenotype rather than the genotype, effective adjustments made during diversifying 
13 
 
selection must result in a “discontinuity (of the current phenotype) at the phenotypic 
level” (Mather 1955). This discontinuity can easily be observed on a phylogenetic tree, as 
a ladder-like topology, reconstructed from sequences collected longitudinally from a 
single HIV-infected individual (Fig. 6). It is readily apparent that the sequences from any 
single time point have limited diversity, but there is substantial diversity generated 
between different time points upon branch length comparison (Grenfell et al. 2004). 
 Concentrated examinations of molecular changes have revealed a plethora of 
surprising viral evolutionary dynamics within a single individual. For example, normally 
progressing HIV-infected individuals typically mount a partially robust neutralizing 
antibody response to a susceptible viral population. After a short period of time, the 
susceptible variants are replaced by neutralization-resistant variants. While one might 
expect that mutations would occur at the antibody binding sites on the virus, mutations 
have actually been found to be sparsely distributed across the env gene, and not at 
binding sites. Rather, mutations more often occur at potential N-linked glycosylation sites 
(PNGS), which act as a carbohydrate based shield (Wei et al. 2003). PNGSs can also 
protect the virus against therapeutics directed towards conserved regions of the viral 
surface. 
 Valuable information can be gained by comparing differences in mutation, 
diversity and other characteristics among multiple longitudinally sampled individuals. 
While HIV progression cannot be exclusively characterized into a few all-encompassing 
profiles, there are clearly individuals that progress much more rapidly or slowly than 
others. Comparison of the viral evolutionary dynamics within individuals at different 
14 
 
 
 
Figure 6. Maximum parsimony tree reconstructed from longitudinally collected 
sequences. This individual (P1) was originally described in Shankarappa et al. (1999) 
and corresponding sequences were used as part of the Chapter 3 analyses (Individual 1). 
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points of the progression spectrum has revealed some surprising discoveries. In a study 
where samples were taken from normally progressing individuals over a span of 6-12 
years, there were consistent shifts within individuals of viral divergence, diversity, and 
quasispecies towards variants demonstrating a co-receptor switch (Shankarappa et al. 
1999). Alternatively, perinatally infected children who experienced different rates of 
disease progression harbored viral populations with different levels of genetic diversity. 
Specifically, children with lower viral loads that experience slower progression to AIDS 
carried a more diverse viral population over time than their more rapidly progressing 
counterparts. Longer branch lengths on phylogenetic trees were correlated with a greater 
accrual of non-synonymous substitutions, indicating stronger selective pressures in the 
slower progressing children (Ganeshan et al. 1997). This finding was also upheld when 
six HIV infected men were compared over time, where increased diversity of the viral 
population could be correlated to prolonged survival (Wolinsky et al. 1996). 
 In the third chapter of this dissertation, I have compared longitudinally sampled 
sequences within and among HIV-1 subtype B infected individuals. By analyzing 
sequences within each individual, I was able to identify temporally-consistent potential 
N-linked glycosylation sites (PNGS) and quantify their impact on divergence of the entire 
viral population within an individual. Inter-individual comparisons revealed that the 
stably encoded PNGSs were consistent across infected individuals, implying that these 
sites are functionally important over the entirety of infection. By mapping the proximity 
of PNGSs to critical binding sites on the gp120 portion of env, I have suggested possible 
roles that PNGSs play in infection both individually and collectively. 
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Inter-individual evolution 
Aside from longitudinally sampled inter-individual comparisons, a wealth of knowledge 
has accrued based on single HIV sequences collected from globally distributed 
individuals. Phylogenetic trees reconstructed from multiple individuals, even over 
different timepoints, do not demonstrate the ladder-like topology seen with intra-
individual trees (Lemey, Rambaut, Pybus 2006). Instead, inter-host phylogenies show 
that multiple lineages display temporal endurance. Taxa comparison on a tree is less 
likely to represent host-specific selective regimes; rather it tells a story about the 
demographic and spatial history of the virus (Grenfell et al. 2004; Lemey, Rambaut, 
Pybus 2006). 
 The first network of HIV infected individuals was not drawn based on genetic 
information, but rather by connecting individuals through sexual contact. The main 
finding, published shortly after reports of AIDS being caused by a retrovirus, was that 
forty of the first reported AIDS cases in ten cities were linked by sexual contact. This was 
consistent with the hypothesis that AIDS could be caused by a sexually transmissible 
infectious agent (Auerbach et al. 1984).Transmission networks, where the true contacts 
are known, are rarely encountered. Phylogenetics is a way around this problem, where the 
evolutionary history can be used to infer transmission networks. A study analyzing 
sequences sampled from 2,126 London-based HIV-infected individuals, primarily MSM, 
found six strongly supported MSM clusters using Bayesian Monte Carlo Markov chain 
phylogenetic analysis (Lewis et al. 2008). They found that 25% of new infections 
occurred within 6 months of the donor’s infection, and that 65% of new infections took 
place between 1995 and 2000. This is important from an intervention standpoint, as 
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education about transmissibility early after infection can be given to at-risk groups. 
Furthermore, they found that in no case did nearest neighbor pairs have the same drug 
resistance mutations, indicating that drug resistant strains were not being transmitted. 
 Biogeographic studies of HIV sequences can give insight into the deep history of 
the virus. Until recently, there was only a single HIV-1 sequence dated prior to 1976. 
Worobey et al. (2008) obtained tissue blocks dating between 1958 and 1960 from 
Kinshasa, where the HIV-1 epidemic is thought to have originated, and screened the 
tissues for HIV-1 RNA. They found a single positive specimen (DRC60), which they use 
to reconstruct a phylogeny, along with a sequence from the same region dating back to 
1959 (ZR59), and 156 other HIV-1 Group M sequences. This revealed that Group M, the 
most successful HIV-1 group, dated back much later than previously estimated; between 
1884 and 1924. Additionally, the fact that DRC60 and ZR59 clustered with different 
subtypes indicates HIV-1 Group M was already extensively variable in the 1950s 
(Worobey et al. 2008). 
 In the next chapter, I examine the relationship between globally distributed HIV-1 
subtype B sequences to further ascertain Haiti’s role in the subtype B pandemic. Groups 
had previously examined the relationship between Haitian-derived sequences and those 
from the rest of the world (Li, Tanimura, Sharp 1988; Gojobori et al. 1990; Korber et al. 
2000; Gilbert et al. 2007) and found the global strains to be nested within Haitian-derived 
strains. I have repeated this analysis, and for the first time incorporated the evolutionary 
force of recombination detection into the evolutionary model. While the identification of 
risk groups is not an outcome of this study, the results contribute, for the first time, an 
alternate possibility to the subtype B pandemic.   
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CHAPTER 2 
RECOMBINATION AFFECTS ORIGIN ESTIMATES: RETHINKING THE HIV-1 
SUBTYPE B GLOBAL PANDEMIC 
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Abstract 
Multiple analyses utilizing phylogenetic inference have all but established that Haiti was 
the final stepping stone for HIV-1 subtype B before the virus achieved pandemic status. 
A recent study clearly demonstrated a well-supported Haiti-first model, indicating that 
the worldwide subtype B pandemic is the result of a single migration event out of Haiti. 
While it is encouraging that multiple studies are in agreement regarding the basal 
placement of Haiti-originating sequences using a variety of phylogenetic methods, they 
also collectively share a single major caveat: each assumes a single evolutionary history 
for the genomic region under scrutiny. Here we show that the majority of positions within 
the env gene support two independently initiated introductions of subtype B epidemics 
after emergence from Africa; one into Haiti and one into the rest of the world. By using a 
conservative recombination detection method based on phylogenetic incongruence, we 
found that multi-partition models fit the env dataset better than single-partition models. 
The paraphyletic and basal clustering of Haiti-originating subtype B sequences was not 
indicated from the phylogenetic reconstruction of three putative non-recombinant env 
segments. Concatenation of the two longest env segments, after putative recombinant 
removal, also supports two independent introductions of subtype B into Haiti and the rest 
of the world. Our results not only oppose the Haiti-first model of the most globally 
widespread HIV-1 subtype, but also indicate that Haiti had little to do with the global 
pandemic in general.  
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Introduction 
HIV evolution is largely modulated by two dominant forces; mutation and recombination. 
The high rate of mutation is due to the low-fidelity reverse transcriptase, which allows for 
rapid expansion across sequence space (Hahn et al. 1986). Fortunately, numerous 
evolutionary models have been developed and are used in phylogenetic analyses to 
describe substitution rates and rate variation. Recombination occurs when reverse 
transcriptase switches RNA strands during cDNA synthesis (Goodrich, Duesberg 1990), 
combining the genetic information from both RNA strands. While strand switching 
between two identical strands is likely, recombination is only detectable when variable 
sites are present between the two strands. State of the art phylogenetic tools implicitly 
assume a single evolutionary history, and as a result, detection of non-recombinant 
segments within recombinants must be carried out prior to topological reconstruction. 
 The earliest phylogenetic trees reconstructed from HIV subtype B sequence data 
have demonstrated a basal and paraphyletic clustering of Haiti-originating sequences 
when compared to the rest of the pandemic (Li, Tanimura, Sharp 1988; Gojobori et al. 
1990; Korber et al. 2000). The most recent of these studies, using Bayesian methods, 
corroborated past findings based on a much larger dataset with highly supportive 
posterior probabilities (Gilbert et al. 2007). The nearly definitive conclusion of research 
conducted by Gilbert et al. (2007) was that Haiti acted as stepping stone between Africa 
and the rest of the world. While the agreement between studies using a variety of 
methods further substantiates the Haiti-first hypothesis of subtype B dispersal, each 
report overlooks recombination and assumes that all sites share identical ancestry.  
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 The goal of this study is to determine if the incorporation of recombination 
detection methods in the analysis of the worldwide subtype B pandemic origin has an 
effect on the basal and paraphyletic clustering of Haiti-originating sequences (Gilbert et 
al. 2007). It was previously suggested that that intra-subtype recombination could not 
“plausibly lead to strains from one locality (Haiti-originating) falling basal to all the 
others (Gilbert et al. 2007).” Admittedly, it does seem improbable that the clear-cut 
systematic clustering of Haiti-originating taxa, forming a paraphyletic clade basal to all 
other subtype B sequences, is an artifact of combining multiple independent evolutionary 
histories. Regardless, given that recombination is a frequently occurring force in HIV that 
can have extensive effects on topology-based inferences (Robertson, Hahn, Sharp 1995; 
Schierup, Hein 2000; Posada, Crandall 2002; Woolley, Posada, Crandall 2008; Martin, 
Lemey, Posada 2011), it is worthwhile to repeat the analysis with the inclusion of 
recombination detection methods. An analysis of this nature is especially necessary since 
results from the previous study have not only affected our knowledge of the geographical 
and temporal spread of HIV-1 subtype B, but also because there are controversial social 
implications at stake that date back to the beginning of the pandemic (Lambert 1990; 
Farmer 1992; Carmichael 2007; Pape et al. 2008). Furthermore, the popular press has 
taken interest in the topic and has popularized the notion of the pandemic subtype B virus 
coming from Haiti (Bowdler 2007; Carmichael 2007). 
Results and Discussion 
To address whether or not recombination has an effect on the inferred geographical path 
of subtype B from a neutral standpoint, we considered four possible outcomes suggested 
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by Gilbert et al (2007): Haiti-first, Pandemic-first, simultaneous and distinct epidemics, 
or an unresolved scenario. It should be noted that for either the Haiti or Pandemic-first 
scenarios that clustering must be both basal and paraphyletic. Basal clustering alone is 
not sufficient for one clade to be nested within the other (Krell, Cranston 2004; Crisp, 
Cook 2005).  
Reproducing Prior Results 
To ensure reproducibility of Gilbert et al. (2007) results, globally distributed datasets 
spanning the gag and env regions identical to those used in the prior study were collected 
(table S1). MrBayes (Huelsenbeck, Ronquist 2001) was used to carry out phylogenetic 
reconstruction of gag1 and env datasets prior to recombination detection. The overall 
topology, indicative of Haiti-originating strains of subtype B falling basal to all others, is 
replicated here using both gag1 and env datasets (Appendix II, Figs 1A and C). While the 
average standard deviation of split frequencies did not drop below 0.01 for either dataset 
(StdDev: gag1 = 0.03, env = 0.19), the log-likelihood values plotted over generation time 
for each individual run did not follow any specific trend, indicating convergence within 
chains (Appendix II, Figs. 1B and D). Conversely, the two independent runs of 20 million 
steps on the env dataset failed to converge to the same solution (Appendix II, Fig. 1D), 
indicating that the number of generations should have been increased or that the 
phylogeny could not be adequately resolved. 
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Recombination Breakpoint Detection 
In analyzing the initial and reproduced trees, we noticed that a single patient was 
represented twice in the gag1 dataset (Appendix II, Fig. 1A, arrows). Both sequences 
AY247251 and AY268493 are derived from Patient AC_06. We expected that sequences 
from the same individual should form a monophyletic cluster in the absence of drug 
resistance mutations, multiple infections or recombination. This finding, coupled with the 
fact that HIV frequently recombines, prompted the use of the Genetic Algorithms for 
Recombination Detection (GARD) program in HyPhy (Kosakovsky Pond et al. 2006) to 
identify recombination breakpoints. This method should be considered conservative in 
breakpoint assignment, as adjacent partitions must be significantly incongruent, per the 
Shimodaira-Hasegawa test (Shimodaira, Hasegawa 1999) in order for a breakpoint to be 
indicated. The gag1 and env datasets each contained two intra-subtype breakpoints, 
yielding three putatively non-recombinant segments a piece (S1, S2 and S3), while the 
gag2 dataset was found to be non-recombinant (Fig. 1 and Appendix I, Tables 2 and 3). 
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Figure 1. Recombination breakpoints. LANL HIV-1 Recombinant Mapper 
(http://www.hiv.lanl.gov/) schematic of identified recombination breakpoints plotted on 
the HXB2 genome. All breakpoints (vertically numbered) were determined using GARD 
and validated (within GARD) using the a posteriori Shimodaira and Hasegawa (SH) test 
for topological incongruence between multiple trees, with the requirement that P < 0.01. 
Inferred coding non-recombinant segments are labeled S1, S2 and S3 for the gag and env 
genes, respectively. While S1 and S3 of the env gene overlap vpu, rev and tat, only cDNA 
from the env gene (frame +3) was examined. 
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  Majority-rule consensus trees (Appendix II, Figs. 2-4) were constructed in 
MrBayes, using non-recombinant segments for comparison to the trees prior to 
recombination detection. Phylogenies drawn from the gag1 and gag2 datasets are largely 
unresolved beyond the monophyletic clustering of subtype B, possibly due to the short 
length of the analyzed segments (Appendix II, Figs. 2 and 3). The reconstructed trees for 
the env segments demonstrated three of the four possible scenarios (Appendix II, Fig. 4). 
The phylogenetic tree representing the evolutionary history from envS1 shows that the 
Haitian sequences form polytomic clades with respect to each other. Although the 
relationship between the different Haitian taxa is largely unresolved, each cluster of 
Haitian sequences is sister to the pandemic clade, indicating simultaneous epidemics. The 
phylogenetic tree reconstructed from the shortest segment, envS2, is star-shaped, which 
may be indicative of a recombination hotspot or high migration (Gilbert et al. 2007). 
Alternatively, there may not be sufficient signal, due to short length, to make a reliable 
conclusion. The envS3 tree clearly demonstrates a Haiti-first scenario, with multiple 
Caribbean sequences clustering within the pandemic clade. 
 In an effort to compare pre-and post-recombination detection dates of the 
worldwide subtype B epidemic onset as well as to reconstruct phylogenies with greater 
resolution, we enforced an uncorrelated lognormal relaxed molecular clock in BEAST 
(Drummond et al. 2012). As in Gilbert et al., (2007), we performed 10 independent 
analyses per non-recombinant segment, each running for 100,000,000 generations. The 
only difference between this and the former analysis is that the non-Caribbean clade is no 
longer limited to the US and a single Canada-originating sequence. The resulting 
phylogenies representing the six non-recombinant segments and the gag2 dataset did not 
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support a Haiti-first topology (Figs. 2-4 and Appendix II, Figs. 5-7). Instead, maximum 
clade credibility trees reconstructed from the majority of env positions present 
relationships more indicative of independent and simultaneous introductions of subtype B 
into Haiti and the rest of the world (Figs. 2 and 4). Phylogenetic reconstruction of the 
shortest env segment suggests that subtype B has been introduced into Haiti multiple 
times during the subtype B pandemic or that the represented region within the env gene is 
a recombination hot spot (Fig. 3). While topological differences between this and the 
previous study suggest drastically different routes of spread for subtype B from Africa 
into the global population, the time to the most recent common ancestor (tMRCA) is 
nearly identical to the previous estimate when comparing the longest env segments (Figs. 
3-5 and Appendix II, Figs. 7A and C). It should be noted that timing estimates using 
different genomic regions and where datasets are expanded beyond a single subtype show 
the tMRCA of subtype B to be well before 1960 (Worobey et al. 2008; Wertheim, 
Fourment, Kosakovsky Pond 2012). 
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Figure 2. Maximum clade credibility tree for genome positions 6231-7406. The maximum 
clade credibility tree reconstructed under a relaxed molecular clock does not support a 
Haiti-first model for the geographical spread of HIV-1 subtype B. Under a Bayesian 
Skyline Coalescent tree prior, the tips are representative of the year of sampling. 
Posterior probabilities are shown where all subtype D, all subtype B, Caribbean subtype 
B and Non-Caribbean subtype B taxa are clustered. Phylogenetic trees were individually 
reconstructed for all 127 sequences spanning HXB2 genome positions 6231-7406. Stars 
represent the TMRCA, where  = Subtype B/D: 1949 (1940-1958),  = Subtype D: 
1959 (1951-1966),  = Haiti/Caribbean Subtype B: 1969 (1966-1973) and  = Non-
Haitian/Pandemic Subtype B: 1968.  
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Figure 3. Maximum clade credibility tree for genome positions 7407-7898. Maximum 
clade credibility tree reconstructed under a relaxed molecular clock do not support a 
Haiti-first model for the geographical spread of HIV-1 subtype B. Under a Bayesian 
Skyline Coalescent tree prior, the tips are representative of the year of sampling. 
Posterior probabilities are shown where all subtype D, all subtype B, Caribbean subtype 
B and Non-Caribbean subtype B taxa are clustered. Phylogenetic trees were individually 
reconstructed for all 127 sequences spanning HXB2 genome positions 7407-7898. Stars 
represent the TMRCA, where  = Subtype B/D: 1940 (1921-1958),  = Subtype D: 
1941 (1938-1969). 
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Figure 4. Maximum clade credibility tree for genome positions 7899-8795. Maximum 
clade credibility tree reconstructed under a relaxed molecular clock do not support a 
Haiti-first model for the geographical spread of HIV-1 subtype B. Under a Bayesian 
Skyline Coalescent tree prior, the tips are representative of the year of sampling. 
Posterior probabilities are shown where all subtype D, all subtype B, Caribbean subtype 
B and Non-Caribbean subtype B taxa are clustered. Phylogenetic trees were individually 
reconstructed for all 127 sequences spanning HXB2 genome positions 7899-8795. Stars 
represent the TMRCA, where  = Subtype B/D: 1953 (1946-1960),  = Subtype D: 
1966 (1961-1971),  = Haiti/Caribbean Subtype B: = 1965 (1961-1969) and  = Non-
Haitian/Pandemic Subtype B: 1966 (1962-1969).  
5
.0
1
9
6
0
1
9
7
0
1
9
8
0
1
9
9
0
2
0
0
0
1
0
01
0
0
9
2
5
1
1
9
6
4
(1
9
6
0
-1
9
6
7
)
H
6
.E
F1
5
9
9
7
3
H
T
5
9
4
.U
0
8
4
4
5
T
T.
A
F2
7
7
0
6
4
H
T
5
9
6
.U
0
8
4
4
6
N
o
n
-C
ar
ib
b
ea
n
 s
eq
u
en
ce
s 
(n
=9
5
)
A
fr
ic
an
 S
ub
ty
pe
 D
Tr
in
id
ad
 a
nd
 T
ob
ag
o
N
on
-H
ai
tia
n
H
ai
ti
an
 o
r 
H
ai
ti
-l
in
ke
d
34 
 
Upon comparison of the trees independently reconstructed from envS1 and S3, 
both of which demonstrated simultaneous and distinct post-Africa epidemics into Haiti 
and the rest of the world, we observed three sequences that switched between the two 
major clades in question (Fig. 5). Despite their Caribbean origin, these taxa clustered 
within the pandemic clade in S3. HT594 and HT596 are sequences sampled from HIV-
infected pregnant women both of whom were residing in Port-Au-Prince, Haiti’s 
notorious slum, Cite Soleil in 1992 (Ruff et al. 1994). Interestingly, despite the fact that 
these two sequences switch clades depending on the examined segment, they maintain a 
strongly supported cluster (Fig. 5A, S7A and C). This indicates that a recombination 
event involving HIV-1 subtype B from both a Haitian and Pandemic individual must 
have occurred and the recombinant strain circulated within the population prior to these 
women becoming infected. A second possibility is that HT594 or HT596 was involved in 
the recombination event and then the other was subsequently infected. Regardless of the 
mode of infection, this highlights the existence of cross-clade recombinants sometime 
between the entrance of subtype B into Haiti (Fig. 5, 1967) and the  most recent common 
ancestor of HT594 and HT596 (1988). Given that Haiti has been identified as a sexual 
tourism hot spot for vacationers from around the world (Hooper 1999), it is not surprising 
that we find recombinants that are chimeras between strains from Haiti and other 
geographic regions. 
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Figure 5. Recombinant Removal and concatenation of envS1 and S3. The simultaneous 
and distinct post-Africa epidemic scenario is recapitulated when recombinants identified 
through phylogenetic discordance are removed. A) When compared, three sequences of 
Caribbean origin that cluster with the Caribbean clade in envS1 switch clades and 
cluster with the non-Caribbean sequences in envS3. B) The first and third env segments 
are concatenated and cross-clade recombinants and H6 are removed. The maximum 
clade credibility tree reconstructed under a relaxed molecular clock does not support a 
Haiti-first model for the geographical spread of HIV-1 subtype B. Under a Bayesian 
Skyline Coalescent tree prior, the tips are representative of the year of sampling. 
Posterior probabilities are shown where all subtype D, all subtype B, Caribbean subtype 
B and Non-Caribbean subtype B taxa are clustered. Phylogenetic trees were individually 
reconstructed for all 123 sequences spanning HXB2 genome positions 6231-7406 and 
7899-8795. Stars represent the TMRCA, where  = Subtype B/D: 1950 (1942-1958),  
= Subtype D: 1961 (1955-1967),  = Haiti/Caribbean Subtype B: = 1967 (1963-1970) 
and  = Non-Haitian/Pandemic Subtype B: 1967(1964-1970). 
 
Given that envS1 and S3 had nearly identical topologies at the level of Caribbean 
versus Pandemic clustering (Fig. 5A), we concatenated the two segments after removing 
the identified recombinants to find out if the simultaneous and distinct epidemic result 
would be replicated (Fig. 5B). Indeed, both the Caribbean and Pandemic sequences form 
monophyletic clades, respectively. Again, the estimated TMRCA of subtype B is 1966 
(Fig. 5), in agreement with Gilbert et al. (2007). 
As mentioned previously, GARD is useful for the identification of breakpoints. 
Through the phylogenetic reconstruction of non-recombinant segments, recombinants 
that have significant topological effects may be revealed. Sequences that only have short 
recombinant stretches or where the recombination event has taken place between more 
similar sequences may be missed. To better pinpoint regions where recombination events 
occur across the envelope gene, the Recombination Detection Program version 4 (Martin 
et al. 2010) was used. When looking across the entire analyzed env region, it is apparent 
that recombinants are scattered throughout. Even after we filtered out recombinant hits 
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that were possibly due to misalignment, the greatest number of recombination events is 
clustered within the envS2 region (Fig. 6). This finding is supportive of a recombination 
hot spot(s) within S2. Beyond estimating locations where recombination has occurred and 
whether there is a cross-clade or intra-clade event, it is difficult to remove putative 
recombinants and redraw the phylogeny. This is because in the case of most events, the 
parent and recombinant sequences could not be disentangled. Regardless, the placement 
of recombinants appears to be roughly in line with the GARD inferred breakpoints. 
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Figure 6: Recombinants identified using RDP. The presence of recombination is verified 
using RDP. All RDP identified-recombinant regions within sequences are plotted along 
the length of the env gene. Recombination events involving: two Caribbean derived 
strains are designated green, two Pandemic strains are gold or Caribbean and Pandemic 
strains are blue. Black lines connecting recombinant regions indicate multiple 
recombination events within the same sequence. GARD-inferred breakpoints are 
designated by the vertical lines separating the segments.  
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Conclusions 
Outside of sub-Saharan Africa, the Caribbean has been most devastated by HIV, 
and until recently, Haiti had both the highest number of people living with HIV and new 
infections per capita within the region (Joint United Nations Programme on HIV/AIDS., 
World Health Organization. 2008; Joint United Nations Programme on HIV/AIDS. 
2011). It has been repeatedly suggested that the significant Haitian presence in the post-
independent Congo region is likely responsible for the entrance of subtype B into the 
Haiti and our results do not oppose that possibility (Hooper 1999; Pepin 2011). 
Alternatively, there were a number of individuals from other countries, included in the 
worldwide subtype B pandemic population, that were also recruited to the Congo for 
teaching and other employment opportunities (Appendix II, Fig. 8) (Kimpesa 1983). It is 
known that at least a few Belgian individuals residing in the area were infected with HIV 
before returning to Belgium (Sonnet et al. 1987). This is not surprising, since Belgium 
had a strong presence in the Congo river basin area beginning in 1884, and officially 
established a colony (Belgian Congo) in 1908 through 1960. While it would be 
interesting to include earlier dating taxa representing other countries where people 
traveled between their homes and the Congo region, there are no publicly available 
sequences. Of course, such a study could also reveal that these early infections were dead 
ends with no connection to the worldwide pandemic.  
Here, we have considered the four possible scenarios of subtype B dispersal after 
Africa, as it applies to Haiti. Our results indicate that after HIV-1 subtype B emerged 
from Africa, there were two subsequent and nearly simultaneous epidemics into Haiti and 
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the rest of the world; the latter has become one of the most severe disease pandemics of 
human history. While the short gag segments and envS2 do not provide much in the way 
of the geographical path that subtype B took, it is reassuring that the longest two 
segments, which were independently analyzed, come to the same conclusion. 
Furthermore, by screening this dataset for the presence of recombination, we were able to 
identify two events where pandemic and Caribbean strains recombined. Once these 
evolutionary contaminants were removed from the dataset, the two segments could be 
joined and displayed, again, the distinct and simultaneous epidemic scenario. The data 
presented here reveal that phylogenies derived from shorter segments, estimated to be 
non-recombinant, indicate that Haiti was not a jumping point for HIV-1 subtype B into 
the rest of the world. 
Methods 
Sequence Collection 
Nucleotide sequences used in the current analyses were downloaded from the Los 
Alamos National Laboratory HIV Database (http://www.hiv.lanl.gov/). Three datasets 
were constructed (Table S1): 1) An envelope (env) dataset composed of 127 coding 
nucleotide sequences spanning HXB2 6231-8795, mimicking the dataset in Gilbert et 
al.(2007) ; 2) A gag dataset composed of the same sequences used in Gilbert et al. 
spanning HXB2 820-1952. This dataset will be referred to as the gag1 dataset.; 3) the 
gag2 dataset is composed of all gag sequences available from individuals that were 
represented in the env dataset and spans HXB2 1198-1866. (Table S1). 
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 Subtype assignments for all sequences were validated using RIP 
(http://www.hiv.lanl.gov/content/sequence/RIP/RIP.html) (Siepel et al. 1995). The 
following parameters were chosen: The HIV subtype consensus alignment was set as 
background, with a window size set at 400, confidence threshold of 95% and global gap-
stripping with all window values plotted. Codon alignments were produced with 
MUSCLE (Edgar 2004) as implemented in MEGA5.0 (Tamura et al. 2011). 
Reproduced Trees 
Phylogenetic analyses were completed using MrBayes (Huelsenbeck, Ronquist 2001). 
The model settings for all constructed trees specified a General Time Reversible Model 
with a proportion of invariable sites and a gamma-shaped distribution to describe site to 
site rate variation (GTR+I+Γ). Although the best fitting model for the gag datasets is 
TN93, MrBayes does not have a complementary model built in. Appropriate models were 
determined using the DNA/Protein Model test in MEGA5 (Tamura et al. 2011). 
 Trees built under the assumption of no recombination were created from the env 
(Fig S1a) and first gag datasets (Fig S1b) to reproduce results in Gilbert et al. The env 
and gag analyses were run for 20,000,000 (×2) and 5,000,000 (×2) generations, 
respectively, with the chains being sampled every 1000 generations. Majority rule 
consensus trees were constructed after a 25% burn-in was applied and Tracer (Rambaut 
2007) was used to ensure convergence within and between chains after a 10% burn-in. 
FigTree (Rambaut 2009) was used to produce all tree figures. 
Intra-subtype Recombination Detection 
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The scan for intrasubtype recombination was restricted to subtype B sequences, as the 
inclusion of subtype D or C outgroup sequences would reduce support for subtype B-
specific breakpoints. The Single Break-Point (SBP) screen for recombination 
(http://www.datamonkey.org/) was used as an initial filter for all datasets (Table S2), 
while GARD (Kosakovsky Pond et al. 2006) was exploited in-house to detect multiple 
recombination breakpoints (Table S3). The 012345 (REV) and 010040 (TrN93) models 
were selected to describe the substitution patterns of the env and gag datsets, 
respectively, for both SBP and GARD. Site-to-site rate variation was modeled by the 
General Discrete Distribution with 6 rate classes. 
The env subtype B dataset was also analyzed with RDP3 (Martin et al. 2010) to 
verify the presence of recombination. RDP (Martin, Rybicki 2000), GENECONV 
(Padidam, Sawyer, Fauquet 1999), Bootscan (Martin et al. 2005), MaxChi (Smith 1992), 
Chimaera (Posada, Crandall 2001), SiSscan (Gibbs, Armstrong, Gibbs 2000), PhylPro 
(Weiller 1998), LARD (Holmes, Worobey, Rambaut 1999) and 3Seq (Boni, Posada, 
Feldman 2007) were used to identify recombinants. Any recombinant was accepted as 
long as it met the additional criteria of causing phylogenetic discordance and was not 
considered to be a possible misalignment artifact. 
Trees Constructed from Non-Recombinant Segments 
Phylogenetic analyses were completed using MrBayes (Huelsenbeck, Ronquist 2001) 
using GTR+I+Γ. Chains for the env and both gag datasets were run 65,000,000 and 
20,000,000 generations, respectively, with sampling every thousand generations. 
43 
 
Majority rule consensus trees and figures were constructed using the same methodology 
as in the reproduced trees. 
Molecular Dating 
For the inference of a time-measured phylogeny that would shed light on the emergence 
of the worldwide HIV subtype B epidemic, molecular dating was estimated using 
BEAST (Drummond et al. 2012). A random start tree was used for each analysis. An 
uncorrelated log-normal relaxed molecular clock, as opposed to the rejected strict clock 
model (LRT: Χ2=180.855, df = 126, P ≤ 0.001), was used to allow variation of the rate of 
evolution among the tree branches, where each branch is drawn from an underlying 
lognormal distribution. A Bayesian Skyline coalescent tree prior was assigned. For each 
individual segment, 10 independent analyses were completed, where each analyses was 
run for 100,000,000 generations. For the envS1 + S3 tree, 4 independent analyses, 
100,000,000 in length, were completed. A burn-in of 10% was applied (10,000,000 
generations discarded per analyses) and the maximum clade credibility tree is displayed 
along with posterior probabilities. It should be noted here, that since subtype D sequences 
were clustering within the subtype B clade in MrBayes trees constructed from both gag1 
and gag2 datasets, we only used subtype C sequences as the outgroup for gag datasets for 
molecular dating. This was to ensure that conclusions about the subtype B clade were not 
affected by the chosen outgroup.  
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CHAPTER 3 
N-LINKED GLYCOSYLATION SITES: EVOLUTIONARY CONTRIBUTION AND 
STRUCTURAL CHARACTERIZATION 
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Abstract 
On the HIV gp120 gene, potential N-linked glycosylation sites (PNGSs) are commonly thought 
to be the positions where mutations are most commonly observed within and among individuals. 
Although collectively the mutational accumulation appears to be great, glycans that attach to 
these sites are required for proper folding and subsequent attachment to the primary host cell 
receptor, CD4. Simultaneously, these glycans provide protection to the virus against host 
immune defenses. For the first time, the evolutionary contribution of PNGSs has been quantified, 
and I statistically determined that greater than half of the divergence of gp120 is due to mutations 
at these sites. Furthermore, from the longitudinally sampled sequences analyzed here, two 
potential N-linked glycosylation sites are identified that are significantly more conserved than all 
others. In addition to the conservation analysis, protein structural analyses, where the PNGSs and 
critical binding sites were mapped to a gp120 structure, were carried out. Results revealed that 
only four PNGSs are situated such that they are the closest to fifty of fifty-two non-overlapping 
binding sites. This suggests an evolutionary strategy to maximize the protective abilities of 
glycans while minimizing their attachment sites. Finally, I found that potential N-linked 
glycosylation sites tend to be closest to binding sites with the greatest flexibility, potentially 
suggesting an environmental preference for occurrence on the protein structure. 
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Introduction 
It has been nearly three decades since the causative agent of Acquired Immunodeficiency 
Syndrome was determined to be a retrovirus, now known as the Human Immunodeficiency Virus 
(HIV). Three years later, in 1987, a nucleoside analog reverse transcriptase inhibitor, 
azidithymidine (AZT), became the first drug approved by the Food and Drug Administration to 
combat HIV (www.fda.gov). Saquinavir, approved in 1995, was the first protease inhibitor 
brought to market (Naeger et al. 2010). To date, at least 36 antiretrovirals are available, 35 of 
which target the viral reverse transcriptase, protease, integrase and/or the gp41 portion of the 
envelope (www.fda.gov). The single commonality among all of these drugs is that they interact 
with protein component of the virus. Given that a substantial fraction, 60 kD of 120 kD (Lasky et 
al. 1986; Geyer et al. 1988), of HIV’s envelope glycoprotein gp120 is composed of N-linked 
glycans, a new therapeutic target is apparent. 
 N-linked glycosylation is a post-translational protein modification that occurs in the 
rough endoplasmic reticulum (RER), where large oligosaccharide precursors are attached to 
asparagines residues that are part of a NX[S/T] tripeptide. Further enzymatic processing in the 
RER yields an N-linked glycan where one mannose and three glucose residues have been 
cleaved from the oligosaccharide precursor. The glycosylated protein is transported by vesicle to 
the Golgi apparatus for further processing. If pertinent parts of the attached oligosaccharide are 
not accessible to mannosidases, which further cleave mannose residues, the protein with its high-
mannose oligosaccharide(s) is the final product. More commonly, in vertebrate cells, the protein 
product will possess complex oligosaccharides. In contrast to the high mannose oligosaccharides, 
two additional mannose residues are removed and three N-acetylglucosamine, one fucose and 
three galactose residues as well as three N-acetylneuraminic acids are attached (Lodish et al. 
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2000). Interestingly, HIV possesses both types of N-linked glycans as well as hybrids between 
the two, with the vast majority consisting of the incompletely processed simple high-mannose 
type oligosaccharides (Lasky et al. 1986; Geyer et al. 1988). 
 The necessity of N-linked glycans was shown with the expression of gp120 in the 
presence of the antibiotic tunicamycin, which blocks the initial transfer of the large 
oligosaccharide precursor in the RER and prevents synthesis of all N-linked glycans. Non-
glycosylated forms of gp120 were unable to bind to the host CD4. It was further discovered that 
the non-glycosylated forms of gp120 were misfolded due to the random formation of disulfide 
bonds. Collectively, this research demonstrated that N-linked glycans are required for the proper 
folding of gp120, and furthermore, without this folding, the virus cannot interact with the host 
cell (Li et al. 1993). 
 In addition to the mediation of correct folding, N-linked glycans also play a major role in 
neutralizing antibody evasion. Comparison of longitudinally sampled sequences from a single 
HIV-1 subtype B infected individual revealed that neutralization resistant viral populations 
primarily contained mutations at potential N-linked glycosylation sites (PNGSs) (Wei et al. 
2003). While PNGSs were primarily gained over time, they were also lost at some positions. 
Moreover, there are paired, and perhaps even more complex interactions between glycans; those 
within proximity to each other tend to have exclusionary interactions, while those more distant 
from each other tend to have inclusionary interactions (Poon et al. 2007). 
 The goal of the current study is to characterize PNGSs through the analysis of sequences 
derived from eleven normally progressing subtype B infected individuals. While many studies 
have verified that PNGSs change over time, none have actually quantitatively evaluated the total 
evolutionary contribution of PNGSs to the viral population within and among individuals. I have 
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further analyzed a portion of PNGSs that are relatively evolutionarily stable over time in an 
effort to understand the roles each stable PNGS plays in relationship to each other, critical host 
protein binding sites and within the general environment where they occur. In contrast to 
analyses that characterize sites by in situ mutation of amino or nucleic acids that are proximally 
located with respect to primary sequence distance (distance between amino acids of interest by 
counting intervening amino acids), I have statistically associated PNGSs with binding sites using 
structural distances. Studies of this nature are more evolution-centric, as selection acts on the 
phenotype (structure) and results in evolutionary changes to the genotype (sequence) and 
phenotype frequencies. 
Results and Discussion 
Effects of PNGSs on Divergence 
To estimate the effect of PNGSs on overall evolutionary divergence of the viral population 
within each individual, two datasets were compared: one with all sites included (ALL) and one 
where all PNGS were removed (PGlyRem). After phylogenetic reconstruction and calculation of 
individual root to tip lengths and sum of branch lengths, the impact of PNGS removal was 
determined through statistical testing. 
 Individual-specific linear regression analyses were carried out to identify: 1) if a linear 
relationship exists between individual branch lengths reconstructed from the ALL and PGlyRem 
datasets, and 2) if divergence of the HIV population is decreased upon removal of PNGS. For 
this analysis, significance cannot be assessed, because shared phylogenetic history of tip 
sequences violates the independence assumption of linear regression. Regardless, by plotting all 
branch lengths from the PGlyRem against ALL dataset, it is apparent that branch length variation 
due to PNGS exists for the majority of taxa sampled from each individual (Fig. 1). The line of 
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expectation (slope = 1), where regression lines should fall if no difference exists between per-site 
branch lengths in the two datasets, has a greater slope than that from any of the individual 
regression lines drawn (Table 1 and Figure 1). 
 
Individual Regression Equation R
2
 
Null 1x + 0 1 
1 0.4003x + 0.0139 0.5193 
2 0.2604x + 0.0073 0.8947 
3 0.2279x - 0.0009 0.8264 
4 0.2135x + 0.0045 0.7947 
5 0.3475x + 0.0006 0.7582 
6 0.2173x + 0.0073 0.7749 
7 0.8223x + 0.003 0.8878 
8 0.2987x - 0.0081 0.832 
9 0.6242x - 0.022 0.662 
10 0.2338x + 0.0116 0.9004 
11 0.1948x + 0.002 0.8517 
Table 1. Individual analysis of PNGS contribution to per-site divergence. Linear regression 
equations and regression coefficients are shown for each taxon branch length in the PGlyRem 
versus ALL dataset, along with the null expectation (Null).
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Figure 1. Individual analysis of PNGS contribution to per-site divergence. PGlyRem branch 
lengths are plotted against ALL branch lengths for taxa sampled from each individual. The thick 
black line represents the line of expectation (m = 1), where removal of glycosylation sites would 
not have had any impact on per-site branch lengths.
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 A second simple linear regression was performed to compare the normalized sum 
of branch lengths between the ALL and PGlyRem datasets. The sum of branch lengths 
for the PGlyRem versus ALL (Appendix III, Table 6) dataset was plotted for each 
individual (Fig. 2), revealing a strong linear relationship. More specifically, nearly 89% 
of the variation in the normalized sum of branch lengths for the PGlyRem dataset can be 
explained the regression (Fig 2). An analysis of variance performed within the regression 
established that the sum of branch lengths in the ALL dataset could statistically 
significantly predict the PGlyRem sum of branch lengths, F (1, 9) = 75.4, p < 0.0005. 
This is expected since the compared phylogenetic trees are equivalent with the exception 
of the PNGS removed in the PGlyRem dataset. The remaining 12% of variation not 
explained by the regression of PGlyRem on ALL, must be accounted for by the removal 
of PNGSs. 
  
56 
 
 
Figure 2. Plotted normalized sum of branch lengths for PGlyRem vs ALL. The dashed 
grey line with slope of 1 (m = 1) indicates what we would expect if there was no change 
between the sum of branch lengths reconstructed from the two datasets. 
 
 The slope of the regression equation (m = 0.34) indicates that branch lengths are 
generally shorter when glycosylation sites are removed. To identify whether or not the 
decrease in divergence, due to the removal of PNGS, is statistically significant, the slope 
of the linear regression line determined from plotting the PGlyRem sum of branch 
lengths against those from the ALL datasets was compared to the slope of the line of 
expectation (m = 1). The comparison revealed that the slope comparing PGlyRem and 
ALL datasets is statistically significantly reduced, indicating a significant reduction of 
divergence experienced by the PGlyRem dataset, t (9) = 16.02, p < 0.0005. 
 As a follow-up to the linear regression tests, a paired samples t-test was used to 
identify if there was statistically significant mean difference between the normalized sum 
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of branch lengths from PGlyRem and ALL (Appendix III, Tables 2 and 3). A single 
outlier was detected but inspection of its values revealed that it was not extreme and was 
therefore retained for the analysis (Appendix IV, Fig. 1). The differences between the 
sum of branch lengths did not statistically significantly deviate from normality as 
assessed by the Shapiro-Wilk test (p = 0.231, Appendix III, Table 4). Phylogenetic trees 
reconstructed from the PGlyRem datasets had shorter sum of branch lengths (0.015 ± 
0.002 substitutions per site) than those reconstructed from the ALL datasets (0.037 ± 
0.006 substitutions per site); a statistically significant decrease of 0.022 (95% CI, 0.013 
to 0.031) substitutions per site, t(10) = 5.391, p < 0.0005, d = 1.62. Given that the two 
datasets used to reconstruct the branch lengths are identical with the exception of PNGS 
removal in the PGlyRem dataset, PNGS are responsible for a 59% reduction of the mean 
divergence (Appendix III, Table 3). Taken together, the regression analysis and paired t-
test indicate that PNGSs are an important source of variation and that a considerable 
amount divergence within gp120 occurs at those sites. 
 The longitudinally sampled paired compartments datasets (Appendix III, Table 5) 
were analyzed to ascertain whether or not compartmentalization, site position and/or 
individual has an effect on the raw conservation of 12 stable PNGSs (> 60% conservation 
for at least 4 of 5 individuals). To compensate for the lack of independence between 
measurements, the Generalized Estimating Equations (GEE) procedure was used. While 
individual (Appendix III, Tables 6 and 7) and site (Appendix III, Tables 8 and 9) had an 
effect on raw conservation (p < 0.0005 for both), there was no effect of compartment 
(Appendix III, Tables 13 and 14). The lack of effect due to compartment indicates that 
both plasma and PBMC derived sequences can be used to make conclusions about PNGS 
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conservation for this dataset. The fact that PNGSs are differentially conserved indicates 
that there may be functional differences between sites. A difference of PNGS 
conservation among individuals is expected if sites are randomly conserved. 
Identification of Differential Conservation Among PNGSs 
A randomization study was carried out to find out which, if any, PNGSs were 
significantly more conserved than one would expect by random chance alone. 
Comparison of stable PNGSs ranked by conservation revealed that all glycosylation sites 
are not randomly conserved among individuals. Rather, two glycosylation sites are 
consistently found to be more conserved than all others (N301, p = 0.012 and N448, p = 
0.034) (Fig. 3 and Appendix III, Table 5). Further investigations also revealed 
significantly more variation in conservation among observed PNGSs than would be 
expected by chance alone (p = 0.0024) (Fig. 4); a finding that further supports the 
hypothesis that PNGSs are differentially conserved.
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Figure 3. Histogram of average rank frequencies. The observed average ranks are 
indicated for each stable PNGS. Sites marked with an asterisk are statistically 
significantly more conserved than other stable glycosylation sites using a one-tailed test.
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Figure 4. Histogram of average rank variances. The variance for each set of 12 randomly 
generated average ranks was plotted, versus the frequency of that variance. The variation 
in conservation for the observed PNGSs is shown with a red arrow and is denoted as 
statistically significant with an asterisk.   
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Characterization Stable PNGS by SASD to Critical Binding Sites 
In an effort to functionally characterize PNGSs, the solvent accessible surface distance 
was calculated between each PNGS and linearly discontinuous critical binding sites on 
gp120 (Appendix III, Table 12). It should be noted that three of the PNGSs could not be 
mapped to 3TGQ and were removed from the structural analyses, reducing the total 
number of analyzed PNGSs to nine. Statistical analyses revealed that mean SASDs 
between a PNGS and the different binding site types (17B, B12, CG10, CD4 and/or 
CCR5) were statistically significantly different (Table 2). 
Site  Levene's Test 
 
ANOVA (or Welch's ANOVA) 
 
Power 
 
 F p 
 
F dfbetween dfwithin p   
N276  1.42 0.240  47.8 4 74 < 0.005  1 
N295*  2.50 0.050  19.3 4 20.6 < 0.005  1 
N301*  3.82 0.018  15.0 4 26.5 < 0.005  1 
N332*  2.90 0.027  22.9 4 21.7 < 0.005  1 
N339  2.30 0.660  6.7 4 74 < 0.005  1 
N356*  2.79 0.032  30.2 4 25.6 < 0.005  1 
N362*  3.79 0.007  21.9 4 23.4 < 0.005  1 
N386*  8.64 < 0.005  15.6 4 22.7 < 0.005  1 
N448*  3.81 0.007  73.8 4 21.8 < 0.005  1 
Table 2. Levene’s test of homogeneity of variances and ANOVA or Welch’s ANOVA 
results. Analyses using the non-parametric Welch’s ANOVA in the case of 
heteroskedasticity are indicated with an asterisk. 
Tukey’s HSD test for multiple comparisons exposed which binding types individual 
PNGSs are positioned significanlty closer to or farther from (Figure 5). In only a single 
case did a PNGS cluster most closely with a single binding type (N276 with CD4) while 
most PNGSs were equidistantly spaced between multiple binding types. This is not 
surprising, as some binding sites partially overlap.
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Figure 5. Tukey’s Honestly Significant Difference (HSD) test for each PNGS. Tukey’s 
HSD was performed for all PNGS sites since means significantly differed between 
different binding types. Binding types clustered together under the same roman numeral 
indicate that mean SASDs did not differ significantly among the clustered types. 
Alternatively, binding types categorized by different roman numerals did have 
statistically significantly mean differences between the indicated PNGS and binding 
types.  
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 Two additional Welch’s ANOVAs were carried out to determine if the average 
SASD among: 1) a PNGS and all binding types significantly differed for any of the 
PNGSs and 2) a binding type and all PNGSs significantly differed for any of the binding 
types. In both cases, there was a statistically significant difference between groups (p < 
0.05, Table 3). The Games-Howell post-hoc tests for multiple comparisons revealed that 
the PNGSs and binding types could be clustered into seven (Fig. 6) and two (Fig. 7) 
overlapping groups based on mean SASD from all binding sites or all PNGSs, 
repectively. 
Site Comparison Levene's Test  Welch's ANOVA  Power 
 F p  F dfbetween dfwithin p   
PNGS 4.9 < 0.005  56.1 8 291.3 < 0.005  1 
Binding Type 14.7 < 0.005  13.4 4 223.6 < 0.005  1 
Table 3. Levene’s test of homogeneity of variances and Welch’s ANOVA output to detect 
mean differences in SASDs. Differences in mean SASDs existed for different PNGSs and 
binding types. 
Next, the SASD between each binding site and the closest PNGS to that binding site was 
examined (Appendix III, Table 13). Interestingly, only six of the nine PNGSs were 
among the closest to a binding site (N276, N295, N301, N362, N332 and N386). Four of 
the sites, N276, N301, N362 and N386, accounted for a noteworthy 96% of the closest 
PNGSs to a binding site. 
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Figure 6. A Games-Howell post-hoc test for multiple comparisons of PNGSs based on 
SASD. This test was performed to identify which PNGSs had significantly different mean 
SASDs from all binding sites. PNGSs clustered together under the same roman numeral 
indicate that mean SASDs did not differ significantly among the clustered sites. 
Alternatively, PNGSs categorized by different roman numerals did have statistically 
significantly mean differences between the indicated PNGS(s) at the 0.05 level. 
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Figure 7. A Games-Howell post-hoc test for multiple comparisons for binding types 
based on SASD. This test was performed to identify which binding types had significantly 
different mean SASDs from all PNGSs. Binding types clustered together under the same 
roman numeral indicate that mean SASDs did not differ significantly among the clustered 
types. Alternatively, binding types categorized by different roman numerals did have 
significantly different mean SASDs from PNGSs at the 0.05 level. 
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Critical Binding Site Flexibility and PNGS proximity 
The dynamic flexibility index and solvent accessible surface area were determined for 
each residue included in chain D of 3TGQ to determine if flexibility or accessibility play 
a role in the placement of stable PNGSs. A histogram of the plotted %DFI for each 
residue revealed a left-skewed, or negatively skewed, distribution (Fig. 8 green bars). All 
stable PNGSs cluster within the rightmost portion of the histogram as their %DFI ranges 
from 81.3% to 99.8% (Appendix III, Table 5). Alternatively, there doesn’t appear to be a 
preference for any particular level of solvent accessibility for gp120, as residues appear to 
have uniformly distributed %ASA (Fig. 8, mauve bars). 
 %DFI and %ASA of binding sites were more closely inspected to identify trends 
that may indicate a relationship between binding site flexibility or solvent accessibility 
and proximity to PNGSs. The shortest SASD between each binding site and the closest 
stable PNGS was plotted against %DFI (Figure 9) or %ASA (Appendix IV, Fig. 2). 
Remarkably, %DFI and SASD clearly exhibit a strong negative correlation (r = 0.86), 
strongly implying that the most flexible binding sites are situated closest to PNGSs. 
Alternatively, no relationship beyond what one would expect randomly could be 
discerned between the shortest SASDs from binding sites to a PNGS (r = 0.04). 
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Figure 8. %DFI and %ASA histogram. The frequency of all sites on 3TGQ, chain D, with 
a given %DFI (green bars) or %ASA (mauve bars) is shown.  
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Figure 9. The shortest SASD for each of the 52 binding sites to the closest PNGS plotted 
against %DFI.  
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Conclusions 
Differential Conservation of PNGSs and Evolutionary Contribution 
The gp120 glycoprotein of HIV is a prime target for therapeutic development, given its 
intimate relationship with the immune system and the fact that it is involved in the initial 
stage of infection; cellular attachment. Despite the appeal of developing drugs that 
interfere with the earliest stages of infection, there are fundamental obstacles that must be 
overcome. Firstly, gp120 experiences an incredibly rapid rate of intra-host evolution, 
8.18E-3 substitutions per site per year (Lemey, Rambaut, Pybus 2006), resulting in a 
robust and diverse quasispecies population. The very crux of a quasispecies is the ability 
to swiftly respond to natural (e.g. neutralizing antibodies) or artificial (e.g. therapeutics) 
selective pressures. In addition, and not mutually exclusive from the former point, an 
evolving glycan shield has been found to offer substantial protection to otherwise 
accessible regions of gp120 less prone to mutation (Wei et al. 2003). In the current study, 
stable PNGSs have been systematically characterized in relationship to each other as well 
as to critical binding sites on gp120. 
 It has been established previously that the number of PNGSs in gp120 tends 
increase over time, although the positions they occur at often differ at any given time 
point (Wei et al. 2003). Despite that fact, many PNGSs are relatively conserved 
throughout infection (Blay et al. 2006). This study establishes and quantifies, for the first 
time, the significant effect of PNGSs on the divergence of gp120 in normally progressing 
HIV-1 subtype B infected individuals. This was accomplished by comparing branch 
lengths of identical maximum likelihood-generated topologies before and after removal 
of positions where PNGSs occur. Strikingly, a 59% reduction in mean divergence 
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(Appendix III, Table 5) is experienced by the PNGS devoid dataset (PGlyRem), 
indicating that, at least in normally progressing individuals, positions encoding PNGSs 
are a major source of variation. 
 Since co-evolutionary toggling (i.e. positional switching) of PNGSs has been 
recognized (Poon et al. 2007), a goal of this study was to identify whether stable PNGSs 
tend to be randomly conserved over the entire course of infection or if some tended to be 
significantly more conserved than others. A randomization analysis was employed to find 
the probability of a PNGS achieving a given average conservation rank among all 12 
PNGSs. Two sites, N301 (average rank of 3) and N448 (average rank of 3.6), were found 
to be highly and non-randomly conserved in both an intra- and inter-individual context 
(Figure 3, Appendix III, Table 5). Furthermore, the variability in conservation of the 
observed PNGSs was significantly higher than what would be expected if the relative 
conservation of the PNGSs was random (Fig. 4). This implies that PNGSs with the 
highest and lowest observed ranks are truly outliers. 
 In order to identify whether or not a structural versus protective role was played 
by each stable PNGS, comparisons between critical binding sites and PNGSs were 
carried out. These analyses were accomplished with a metric referred to as the solvent 
accessible surface distance (SASD) which provides a more accurate estimate of the 
distance between given sites than popular, yet antiquated, methods of counting amino 
acids between sites or even calculating the Euclidean distance in the three-dimensional 
structure (Kahraman, Malmstrom, Aebersold 2011). A crucial assumption of this study is 
that in order for a glycan attached to a PNGS to convey protection from the immune 
system, or aid in the binding of a particular site, proximity to the glycan is required. 
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Given that average length of an N-linked glycan is 30 angstroms, that length is assumed 
to be a near maximum breadth of protective coverage here (Rudd et al. 1999). In 
accordance with that length, it should not be surprising then that SASDs calculated for 
fifty of fifty-two binding sites (excluding T123 and K117) were within 30 angstroms of a 
stable PNGSs (Appendix III, Table 13). Remarkably, only four of the nine PNGSs 
included in the structural analyses accounted for the closest PNGSs to 96% of the binding 
sites. The placement of only four stable PNGSs within a proximal and putatively 
protective distance from fifty critical binding sites is an extraordinarily clever strategy 
which may minimize mutational accumulation while maximizing protective potential. 
Upon visual inspection, it is apparent that these four PNGSs form are situated at the 
anterior-most boundary of the binding sites mapped here. In addition, fewer glycans near 
critical binding sites may result in a decrease of steric hindrance of cellular receptors 
(Fig. 10). While N301 is the most conserved stable PNGS, N362 is actually one of the 
least conserved. It is possible that in the absence of the PNGS at N362 that PNGSs at 
N276 and N386, or more transiently occurring PNGSs, could collectively compensate for 
the loss. Expanded studies focusing on these binding site-proximal PNGSs may reveal 
co-evolutionary processes in the face of glycan-specific selective pressures. Future 
mutational analyses should take into account these SASD findings rather than sequence 
distance to better account for interactions between binding sites and PNGSs. 
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Figure 10. Stable PNGSs and other sites of interest mapped on the 3TGQ protein 
structure. CG10 binding sites are colored in teal, 17B in purple, CCR5 in red, and the 
PNGSs are colored in black. The right structure is rotated around the y-axis to show all 
stable PNGSs and binding sites. 
 
 Included in the four PNGSs that were found to be closest to the most binding 
sites, is N301, which I also determined to be significantly more conserved than eleven 
other PNGSs (Fig. 3). In a prior mutational analysis, where the asparagine at position 301 
was conservatively mutated to a glutamine, it was revealed that the mutant virus was 
unable to replicate in PBMCs (Ogert et al. 2001). Interestingly, N301 was only conserved 
in 64% of sequences sampled from individual 7 (analyzed here) despite a persistent viral 
load (Shankarappa et al. 1999). SLAC results indicate that variants harboring non-
synonymous mutations to aspartic acid, glutamic acid, glycine, lysine and threonine were 
positively selected in favor of variants with asparagine in this individual (Appenidix IV, 
Fig. 3). Since the viral population sampled from individual 7 was collectively dual-tropic 
(able to use either co-receptor) from nearly the onset of infection (Shankarappa et al. 
1999), it is possible that the maintenance of viral load was due to a co-receptor switch. 
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 In addition to the conservation analyses, N301 was found to be most closely 
situated with and equidistantly placed in proximity to CCR5, 17B and CG10 binding sites 
(Figs. 5, 10 and 11) which do have some overlap. CCR5 is considered to be the primary 
co-receptor, as most strains utilize CCR5 at the onset of infection (Coakley, Petropoulos, 
Whitcomb 2005). 17B and CG10 are CD4 induced antibodies, as binding is enhanced in 
the presence of soluble CD4, indicating that a conformational shift exposes their binding 
sites after CD4 is attached (Zhang et al. 1999). These results, taken together with the high 
conservation of N301 and its close proximity to binding sites suggest this PNGS is both 
critical for co-receptor binding activity and may play protective role against 17B and 
CG10. 
 
Figure 11. N301 and other sites of interest mapped on the 3TGQ protein structure. CG10 
binding sites are colored in teal, 17B in purple, CCR5 in red, and the PNGS site, N301, is 
colored in black. The structure is rotated around the y-axis to show the binding sites 
centered around N301. 
  
 
 A second PNGS, N448, was also found to be significantly more conserved than 
nine other stable PNGSs. In contrast to the SASD results seen with N301, N448 is 
located farthest from all critical binding sites analyzed here (Figs. 5 and 10 and Appendix 
III, Table 12). Interestingly, a study testing the neutralizing activity of a prokaryotic 
lectin, actinohivin, also examined PNGS deletion in response to the selective pressure. 
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Actinohivin preferentially binds to high mannose sugars, which N448 may be occupied 
by, rather than complex sugars. Despite persistent sub-cultivations for actinohivin-
resistant strains of HIV-1 subtype B infected CEM T-cells, with escalating concentrations 
of actinohivin, N448 persisted (Hoorelbeke et al. 2010). Furthermore, N448 is located 
directly proximal to another PNGS, N262 (Fig. 12), which was not included in this study 
due to lack of sequence coverage. Deletion of N262 results in a significantly hindered 
ability to attach to CD4, due to lowered overall expression of gp120 in the viral particle 
(Francois, Balzarini 2011). Given the proximity of N448 to N262, along with the fact that 
a non-synonymous mutation was not observed in the face of a strong selective pressure 
against this type of PNGS, and that it is more than 50 angstroms away from any of the 
binding sites, it is likely that the highly conserved nature of this PNGS is not to maintain 
immunological protection, but may instead play a role in structural integrity. 
 
Figure 12. N262 (blue) and N448 (black) mapped on the 3TGQ protein structure. 
 
 As a final attempt to determine characteristics of binding sites that PNGSs cluster 
closest to, the dynamic flexibility index (DFI) was calculated as a comparative 
percentage (to the rest of the molecule) for each binding site. I found that binding sites 
falling closer to a PNGS were more flexible than those clustering farther away (Fig. 9). 
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This presents two possibilities. First, it is possible that flexible binding sites are more 
susceptible to neutralization than there rigid counterparts. Alternatively, it may be that 
PNGSs preferentially occur in areas where the surrounding amino acids are more 
flexible, possibly to allow for the attachment of a large glycan moiety. Future studies will 
include the elucidation of DFI for all the amino acids immediately surrounding the 
PNGSs. 
Methods 
Sequence Selection 
Previously published HIV-1 subtype B partial env nucleotide sequences, longitudinally 
sampled from peripheral blood mononuclear cells (PBMC) and/or plasma from eleven 
infected individuals (Shankarappa et al. 1999), were collected from the Los Alamos 
National Laboratories HIV database 
(http://www.hiv.lanl.gov/content/sequence/HIV/mainpage.html). In addition, descriptive 
information for each sequence was also collected, and included sampled compartment, 
time since seroconversion, CD4 count, viral load and treatment history. Sequences were 
codon aligned in MEGA 5.10 (Tamura et al. 2011) using MUSCLE (Edgar 2004a; Edgar 
2004b). 
Datasets 
Sequences were organized according to the statistical test being performed (Table 4). For 
each individual, the following datasets were created: 1) A paired compartment dataset 
where time points were only represented if sequences from both PBMC and plasma 
compartments were present, 2) A PNGS-void dataset (PGlyRem) where any position in 
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an alignment was removed if a PNGS sequon was present for any sequence and 3) A full 
dataset (ALL) where all sequence with all positions were included. 
 
 
Individual Available Paired PGlyRem ALL 
 PBMC Plasma    
1 87 50 NA 137 137 
2 133 150 193 283 283 
3 106 24 NA 130 130 
4 Mixed NA 250 250 
5 191 44 138 235 235 
6 97 32 59 129 129 
7 107 100 63 207 207 
8 119 82 57 201 201 
9 121 16 NA 137 137 
10 Mixed NA 202 202 
11 0 52 NA 52 52 
Table 4. Count of sequences in each dataset. For some individuals, sequences originating 
from both compartments were not available, resulting in the individual being non-
applicable for the paired dataset. 
 
Selection Detection 
The Single-Likelihood Ancestor Counting (SLAC) method was use to identify sites under 
operating under selective regimes other than neutral (Kosakovsky Pond, Frost 2005). A 
p-value of 0.1 was used to ascertain significance, as SLAC has been determined to be a 
conservative method that returns fewer false positive than one would expect at a p-value 
of 0.05. A general reversible model was used to account for codon substitutions. 
Phylogenetic Trees 
Maximum likelihood trees were reconstructed for the PGlyRem and ALL datasets in 
MEGA 5.1. The best fitting model for the env datasets is the General Time Reversible 
(GTR) + invariant sites + Γ model as determined by the model selection tool in MEGA. 
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The Γ parameter was calculated for each individual’s entire collection of sequences, also 
in MEGA. For each of the eleven ALL datasets, a maximum likelihood phylogenetic tree 
was reconstructed in MEGA and the Newick files with branch lengths were saved. The 
topology of each maximum likelihood tree was retained and taxa from PGlyRem datasets 
were mapped to the branches. New branch lengths were calculated for each tree through 
the Analyze User Tree function in MEGA. This effectively produced two trees with 
identical topologies where branch lengths differ only due to the presence (ALL) or 
absence (PGlyRem) of PNGS. For each tree, an outgroup consisting of sequences 
sampled most closely to seroconversion was chosen and branches were reorganized. For 
paired trees, the same outgroup was always chosen. 
Phylogenetic trees reconstructed from the PGlyRem and ALL datasets were 
uploaded to TreeRate at 
http://www.hiv.lanl.gov/content/sequence/TREERATEv2/treerate.html. The outgroup 
rooting method was used to extract the distance from the rootmost node to each tip as 
well as the sum of branch lengths for each tree (Appendix III Table 1) (Maljkovic Berry 
et al. 2007; Maljkovic Berry et al. 2009). The sum of branch lengths was normalized to 
the number of sequences in each dataset.  
Glycosylation Site Identification 
Glycosylation sequons (NX[ST]) were identified within each dataset using the N-
Glycosite tool at http://www.hiv.lanl.gov/content/sequence/GLYCOSITE/glycosite.html 
(Zhang et al. 2004). Default parameters were used, which includes disregarding any 
sequon with a proline in the central (X) position. A raw conservation metric was defined 
by counting the total number of predicted glycosylation sites at any given position and 
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dividing that count by the total number of sequences in the dataset. As an example, for 
one PNGS position in a dataset composed of 10 sequences, if 5 sequences have the 
sequon NQS and the other 5 have NST, the % raw conservation is 100%. Only stable 
glycosylation sites (Appendix III Table 5), where greater than 60% of the sequences in 
four out of the five individuals, were retained for statistical testing of site-specific 
conservation. 
Stable sites were ranked by % raw conservation, for each individual due to the 
issue of dependence where multiple sites are nested within an individual. Ties between 
sites where % raw conservation is equal in an individual were broken by determining the 
underlying nucleotide genetic distance at the sequon positions using a JC69 substitution 
model. This model was chosen in favor of those with more parameters to avoid over-
fitting, as the number of nucleotide sites is small per sequence (n = 9). Those sites with a 
shorter genetic distance (i.e. more conserved) were given a lower rank (Appendix Table 
1). 
Structural Analysis 
The unliganded HIV-1 subtype B gp120 structure, 3TGQ (chain D) (Kwon et al. 2012), 
was obtained from the Protein Data Bank. Binding sites on gp120 were determined from 
a literature search for the cellular receptors, CD4 (Wu et al. 2009) and CCR5 (Rizzuto et 
al. 1998), and also the neutralizing antibodies, B12 (Wu et al. 2009), 17B and CG10 
(Rizzuto et al. 1998). The solvent accessible surface distance (SASD) and Euclidean 
distance between the beta carbon of the asparagine for each stable PNGS and the beta 
carbon of each binding site were determined with XWalk (Kahraman, Malmstrom, 
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Aebersold 2011) (Appendix III Table 12) and graphical representations were generated 
with The PyMOL Molecular Graphics System, Version 1.5.0.4 Schrödinger, LLC. 
 Quantification of the structural fluctuation of each protein residue within 3TGQ 
was carried out by using the dynamic flexibility index (Nevin Gerek, Kumar, Banu 
Ozkan 2013) (Appendix III Table 14). Accessible surface area was calculated using 
Surface Racer (Tsodikov, Record, Sergeev 2002). 
Statistical Tests 
For the comparison of sum of phylogenetic tree branch lengths in the PGlyRem 
versus ALL dataset, both paired t-test and regression analyses were carried out in an 
attempt to identify whether or not there is an effect of PNGS on divergence. Specifically, 
both tests were used here to determine if the differences between branch lengths 
reconstructed from the two datasets were statistically significant. Testing was carried out 
in SPSS version 21. 
 Slope comparison was carried out using the slope of the line where the sum of all 
branch lengths for each individual in the PGlyRem dataset was regressed on those for 
each individual in the ALL dataset. To compare the observed slope versus expected 
slope, where mobserved = 0.3433 and mexpected = 1, a Student’s t-test was conducted in 
EXCEL. 
   
                         
  
 
 
βestimated, or the parameter value estimate, is equivalent to the observed slope for the 
regression line for the total sum of branch lengths of PGlyRem to ALL. βhypothetical, or the 
hypothesized parameter value, is the slope that is expected if there is no change in the 
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sum of branch lengths after PNGS are removed. Sb is the standard error of the parameter 
value estimate and was found to be 0.066. 
Longitudinal analyses were executed on the paired compartments datasets to 
assess whether or not there is an effect of patient, compartment or site on the % raw 
conservation of PNGS. The generalized estimating equations (GEE) procedure, 
implemented in SPSS version 21, assuming an unstructured correlation matrix was used 
to account for the lack of independence for sites nested within each sequence, sequences 
nested within each time point, and time points nested within each individual. Rather than 
model the within-subject covariance structure, the GEE procedure treats it as a nuisance 
parameter and the mean response is modeled instead. 
A randomization analysis was carried out on the paired compartments aligned 
datasets to test the hypothesis that certain stable glycosylation sites are conserved more 
than others versus the null hypothesis that all glycosylation sites are randomly conserved. 
Briefly, the number of sites to be scrutinized (12) and the number of individuals we had 
observations for (5) were used as input. The 12 ranks were shuffled for each individual 
and the average rank for all individuals was calculated 9,999 times. This resulted in 
119,988 average ranks (9999 for each site). The 12 observed average ranks were added to 
yield a total of 120,000 average ranks. 
A one-way analysis of variance (ANOVA) or Welch’s ANOVA (in the case of 
heteroscedasticity) was performed for each stable PNGS, where SASDs were grouped by 
type of binding site (17B, B12, CCR5, CD4 or CG10), to identify whether or not there 
was an effect of binding site type on the distances. If the null hypothesis of homogeneity 
of variances was rejected by way of Levene’s test (Table 3), the non-parametric Welch’s 
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ANOVA was used. If between group differences were found to be significant, ANOVAs 
were followed up with the Tukey’s Honestly Significant Difference (Tukey’s HSD) post 
hoc test for multiple comparisons while Welch’s ANOVAs were followed up with both 
Tukey’s HSD and the Games-Howell test for multiple comparisons. One important note 
here is that the few outliers present in the data were not removed as the binding sites are 
the true binding sites rather than samples to reflect the binding site population. 
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CHAPTER 4 
CONCLUSIONS AND FUTURE DIRECTIONS 
The human immunodeficiency virus (HIV) has proven to be a resilient opponent in the 
arms race against the host immune system, as it appears to have efficiently perfected its 
strategy to continually infect host cells despite a long lived dynamic host response. An 
analogy for such an arms race was provided by Dawkins and Krebs (1979), using the 
predator-prey relationship of the fox and rabbit. Individually, a fox chases a rabbit, and 
the fox may catch the rabbit, or the rabbit may escape. Over the evolutionary timescale, 
this exercise occurs many times, and while the fox lineage may accrue adaptations for 
hunting, the rabbit lineage may also evolve adaptive mechanisms for escape. This 
biological arms race, where both lineages are faced with the ultimate selective pressure of 
survival, results in antagonistic coevolution. The interplay between HIV and the infected 
host is similar to the fox and rabbit paradigm; the host immune system is in constant 
pursuit of the viral population, and while both are continually changing, they also 
equivalently persist to a point. Normally progressing hosts typically have robust T-cell 
and antibody responses, constantly adjusting to the viral variants at a given time. This is 
apparent in the ability of contemporaneous sera sampled from the infected person to 
neutralize contemporaneous and earlier viral variants, but not viral isolates from later 
time points (Bunnik et al. 2008). Likewise, the viral quasispecies is constantly shifting 
towards the most-fit variants given the host selective pressures (Kohler, Goudsmit, Nara 
1992; Bunnik et al. 2008). The predator and prey continue the chase until the host 
immune system fails, typically after 10 years in drug-naïve normally progressing 
individuals (Coffin 1995). 
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 The driving force of HIV’s successful campaign against the immune system is 
primarily the low-fidelity of reverse transcriptase (Preston, Poiesz, Loeb 1988), which is 
the source of both recombination (Hu, Temin 1990; Jetzt et al. 2000) and mutation 
(Coffin 1995). While each of these mechanisms plays a role in the viral population’s 
evolutionary dynamics within and among individuals, the conclusions made from each 
type of study are often quite different. 
 Results from cross-sectional studies, where viral strains are sampled from 
multiple infected individuals over temporal or geographical space, may reveal the timing 
and location of epidemic origins as well as the spread (Lemey, Rambaut, Pybus 2006). 
This approach has informed us of myriad historical periods in the HIV evolutionary 
timeline, including, 1) multiple cross-species transmissions have introduced HIV into 
humans (Hahn et al. 2000), and 2) that HIV likely originated in west equatorial Africa, 
which is the only place in the world where HIV-1 groups M, N and O co-circulate 
(Nkengasong et al. 1994; Delaporte et al. 1996; Takehisa et al. 1998). In addition, it was 
determined that chimpanzees living in the same region are infected with close relatives to 
HIV (Gao et al. 1999; Hahn et al. 2000). Inter-individual phylogenies have also been 
employed for public health purposes, such as solving criminal cases (Machuca et al. 
2001; Metzker et al. 2002; Lemey et al. 2005; Scaduto et al. 2010; van der Kuyl et al. 
2011) or to identify susceptible individuals and develop intervention strategies (Lewis et 
al. 2008; Dennis et al. 2012). 
 In the second chapter of this dissertation, I performed a cross-sectional analysis to 
better understand Haiti’s role in the HIV-1 subtype B pandemic. Previous analyses 
published phylogenies demonstrating that Haiti-originating strains of HIV clustered 
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ancestrally to subtype B strains originating elsewhere across the globe (Li, Tanimura, 
Sharp 1988; Gojobori et al. 1990; Gilbert et al. 2007). While each of these studies 
incorporated appropriate substitution and site rate models to model mutation, they 
disregarded the possibility of recombination. A considerable amount of controversy has 
been centered on Haiti with regards to the subtype B pandemic, starting when Haitians 
were recognized as a risk group (CDC 1982) and refueled when Haiti was labeled as the 
jumping point for subtype B into the rest of the world (Gilbert et al. 2007). 
 The goal of this project was to first identify if recombination could be detected in 
the Gilbert (2007) dataset, and then to determine if phylogenies reconstructed from 
putatively non-recombinant segments implied an evolutionary history different from 
those previously proposed. The intent of this study was not to impact HIV from a medical 
perspective, but rather to more accurately inform the historical record by using all 
possible tools to model the evolutionary history. 
 Recombination detection within HIV subtypes is a difficult task in comparison to 
inter-subtype recombination, but is becoming more feasible with increasing 
computational power. As stated previously, the parents of the recombinant sequence must 
be divergent enough such that recombination can be detected in the viral progeny. 
Regardless, recombination breakpoints were identified with both GARD and RDP. 
Phylogenetic reconstruction of the three putatively non-recombinant segments identified 
in GARD does not support a Haiti-first model of subtype B dispersal. Instead, the two 
longest segments, which are displaced by an intervening segment, support near-
simultaneous entries of subtype B into Haiti and the rest of the world. A secondary 
phylogenetic analysis, after the removal of cross-clade recombinants and concatenation 
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of the two largest segments, again revealed a topology indicative of simultaneous 
entrances into Haiti and the rest of the world. While the posterior probabilities on the 
Caribbean cluster are lower than the confidence intervals obtained in Gilbert (2007), it is 
encouraging that topologies from the longest two segments, individually and combined, 
support the simultaneous entrances of subtype B into Haiti and the rest of the world. 
 Given the temporal and geographic breadth of sequences included in the 
described cross-sectional study, it is likely that the datasets used here and previously are 
highly representative of all publicly available subtype B sequences. Unfortunately, 
despite the fact that there are early documented cases of HIV in Belgian individuals who 
were residing (either permanently or temporarily) in the area where HIV almost certainly 
entered the human population (Sonnet et al. 1987), there are no representative sequences 
available. The addition of some of these and other earlier strains to the currently 
constructed datasets would likely increase the accuracy of the historical record. 
 Longitudinal studies, where the viral population from the same individual(s) is 
studied temporally, are useful for understanding host-pathogen coevolutionary dynamics. 
For example, administration of therapeutics targeting a particular region of HIV results in 
an increase of escape mutations within an infected individual, where drug-resistant 
variants can be observed within 14 days (Wei et al. 1995). Similarly, variants in the HIV 
population, harboring neutralizing antibody escape mutations, tend to increase in 
frequency in response to the particular neutralizing antibody elicited at a particular time 
point (Albert et al. 1990). Interestingly, while intuition would lead us to suspect that 
resistance-conferring mutations would occur at the antibody binding sites, a longitudinal 
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study revealed that the majority of mutations actually occur at potential N-linked 
glycosylation sites (PNGSs) (Wei et al. 2003). 
 The third chapter of this dissertation is based on a longitudinal analysis where 
sequences sampled from 11 subtype B-infected individuals over a period of 6-12 years 
were analyzed in an attempt to functionally characterize viral PNGSs (Shankarappa et al. 
1999). PNGSs are the most evolutionarily dynamic sites within one of the most 
evolutionarily dynamic proteins identified to date (Wei et al. 2003). The attachment of 
carbohydrates to the PNGSs allows the virus to go undetected by antibodies specific for 
particular protein targets on the gp120 surface. After identifying PNGSs that are highly 
conserved on gp120, I estimated their solvent accessible surface distance to critical 
receptor and antibody binding sites. Customarily, site-directed mutagenesis targets, to 
identify sites of importance, are highly based on the sequence distance between sites. 
While it may not be the intent, this practice intrinsically and incorrectly assumes a 
positive correlation between the distance between sites within the sequence and the 
distance between the same sites on the protein surface. For example, two PNGSs, N262 
and N448, are 226 amino acids away from each other, yet they are positioned directly 
next to each other on the protein structure. Given that N262 appears to be indispensible 
for replication (Francois, Balzarini 2011), coupled with the lack of proposed functionality 
for N448 despite its high conservation in the presence of strong selective pressures 
(Hoorelbeke et al. 2010), it may be worthwhile to investigate the interplay between the 
two sites. Is N448 also important for replication? Does N448 play a protective role for 
N262? These are the types of questions one can take into account when considering the 
spatial proximity of PNGSs. The same type of consideration should be given to the four 
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PNGSs that run along the anterior border of the critical binding sites on gp120. Can 
PNGSs N386 and N276 compensate when the viral variant is missing the more centrally 
positioned yet less conserved N362? Is the highly conserved PNGS N301, which is 
centrally located between all CCR5 binding sites, decreasingly conserved in infected 
individuals where a high frequency of viral variants have undergone a co-receptor switch 
to CXCR4? Could decreased frequency of N301 be used as an early indicator that the 
viral population within an individual will soon undergo a co-receptor switch, resulting in 
resistance to the CCR5-antagonist they are taking? These are all questions that can be 
asked when taking into account the co-evolutionary dynamics between the host immune 
system and viral PNGSs. 
 It is apparent from earlier research as well as the body of work presented here, 
that multiple evolution-driven approaches must be taken to understand what makes HIV 
“tick.” The cross-sectional analysis contributes to the socio-economic and historical 
perspectives of HIV while the longitudinal analysis offers some direction to medical 
research. As such, the work performed over the course of this dissertation further 
validates the potential of evolutionary analysis to investigate a complex study system.   
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Table 1 
   
GAG ENV 
Country 
Sub 
type Patient ID Accession  RIP Accession  RIP 
IN C 93IN904 AF067157 95     
CD D ELI A07108** NS A07108 95 
CD D NDK A34828** 95 M27323 95 
CD D 84ZR085 U88822** 95 U88822 95 
UG D 99UGK09958 AF484499** 95 AF484499 95 
UG D 99UGE13613 AF484515** 95 AF484515 95 
US B H6 EF362776** 95 EF159973 95 
US B H3 EF362774** 95 EF159971 95 
US B H2 EF362773** 95 EF159970 95 
US B H5 EF362775** 95 EF159972 95 
US B H7 EF362777 95 EF159974 95 
Us
a
 B WMJ K03457* 95 M12507 95 
US
a
 B US4 AY173955* 95 AY173955 95 
US B RF M17451* 95 M17451 95 
Kr
a
 B KR5086     AJ417429 95 
Br
a
 B 92BR020     AY669718 95 
HT B 593     AY669721 95 
HT B HT594     U08445 95 
HT B HT596     U08446 95 
HT B HT599     U08447 95 
HT B HT651     U08441 95 
HT B HT652     U08443 95 
TT B QH0679     AF277064 95 
TT B QH0060     AF277055 95 
TT B QH0016     AF277059 95 
TT B QH1420     AF277075 95 
TT B QH0515     AF277061 95 
TT B QH1116     AF277074 95 
TT B QH0020     AF277056 95 
TT B QH0791     AF277068 95 
TT B QH0908     AF277072 95 
TT B QH0605     AF277063 95 
TT B QH0605     AF277057 95 
US B US1 AY173952** 95 AY173952 95 
FR B HXB2LAIIIIBBRU K03455** 95 CS793683 95 
US B DH12_3 AF069140** 95 AF069139 95 
GA B OYI_397 M26727** 95 M26727 95 
GB B GB8 AJ271445** 95 AJ271445 95 
US B NY5CG M38431** 95 M38431 95 
 106 
 
US B WCIPR U69584** 95 U69584 95 
US B US3 AY173954** 95 AY173954 95 
US B US2 AY173953** 95 AY173953 95 
BR B BZ167 AY173956** 95 AY173956 95 
ES B 89SP061 AJ006287** 95     
US B MNCG M17449** 95 M17449 95 
DE B D31 U43096** 95 AY247223 95 
US B AD87/ADA AF004394** 95 AY426119 95 
DE B HAN U43141** 95 U43141 95 
US B YU_2 M93258** 95 M93258 95 
US B SF33 AY352275** 95 AY352275 95 
CO B PCM039 AY561239* 95 AY561239 95 
AR B ARCH054 AY037268* 95 AY037268 95 
NL B ACH3202A21 U34604* 95 U34604 95 
AU B MBC18 AF042102* 95 AF042102 95 
US B WEAU160 AY037282* 95 AY223743 95 
US B P896 AF042102* 95 U39362 95 
CO B PCM001 AY561236* 95 AY561236 95 
US B BC_BCSG3 L02317* 95 L02317 95 
US B CDC451-b M13136* 95 M13137 95 
US B MBC925 AF042101* 95 AF042101 95 
US B MBC200 AF042100* 95 AF042100 95 
AR B ARMA132 AY037282* 95 AY037282 95 
EC B EC102 AY173960* 95 AY173960 95 
AR B ARMS008 AY037269* 95 AY037269 95 
ES B 89SP061 AJ006287* 95 AJ006287 95 
CO B PCM013 AY561237* 95 AY561237 95 
US B Ac_06 AY268493 95     
US B Ac_06 AY247251 95     
KR B WK AF224507 95     
US B JR U63632/M38429 95 AY426125 95 
US B WR27 AF286365 95     
US B 1057_01 AY331292 95     
US B 1299_d22 AY308761 95     
US B 98USHVTN941c1 AY560110 95     
RU B 04RU128005 AY682547 95     
US B 1012_08 AY331285 95     
US B 1013_03 AY331287 95     
TH B BK132  AY173951 95     
US B ARES2 AB078005 95     
CA B WC10C_10 AY314061 95     
JP B JH31 M21137 95     
US B P896 U39362 95     
RU B 04RU129005 AY751406 95     
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US B BC_BCSG3 L02317 95     
MM B mSTD101 AB097870 95     
CN B 02HNsmx2 AY275557 95     
GB B CAM1 D10112 95     
RU B 04RU139095 AY819715 95     
TW B TWCYS_LM49 AF086817 95     
US B SF2 K02007 95     
CA B CANA1FULL AY779564 95     
CA B CANC2FULL AY779559 95     
CA B CANB3FULL AY779553 95     
ZA B 99ZASM1     AY505010 95 
US B 1304_d31     AY308762 95 
KR B KR3026_C1     AJ417426 95 
US B C16     U84841 95 
US B C08     U84799 95 
US B C09B     U84831 95 
US B C13D     U84833 95 
FR B PIH160     AF041131 95 
FR B PHI159     AF041128 95 
US B 93US073     U79721 95 
KR B KR2057     AJ417423 95 
TH B 92TH014C_n     U08801 95 
US B 92US657     U04908 95 
US B SFMHS19     AF025762 95 
US B SFMHS6     AF025754 95 
US B SFMHS7     AF025755 95 
US B SFMHS4     AF025752 95 
JP B JH32     M21138 95 
US B 81CA2     AY247219 95 
FR B PIH374     AF041133 95 
FR B 133-L-1     AY535433 95 
US B 92US727     U79720 95 
GB B 876CD372     AJ535615 95 
US B 056     AY669719 95 
FR B PIH155     AF041130 95 
US B C04B     U84821 95 
US B R2     AF128126 95 
US B 81NJ     AY247221 95 
US B 81CA1     AY247218 95 
US B 81NY3     AY247224 95 
US B 81NY1     AY247222 95 
US B SFMHS20     AF025763 95 
KR B KR5058     AJ417411 95 
KR B KR3042     AJ417409 95 
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US B SFMHS2     AF025750 95 
US B SFMHS8     AF025756 95 
CA B 82CAN     AY247225 95 
US B SFMHS18     AF025761 95 
US B SFMHS3     AF025751 95 
US B 81NY2     AY247223 95 
US B C11     U84806 95 
US B C14     U84850 95 
US B C10     U84800 95 
GB B 822CD341     AJ535610 95 
FR B PIH373     AF041134 95 
US B C12     PIH373 95 
US B 92US716     U08452 95 
US B 712     AY669725 95 
US B 92US715_6     U08451 95 
US B C17B     U84814 95 
US B SF2B13     L07422 95 
GB B 749CD352     AJ535607 95 
US B C05D     U84823 95 
FR B PHI153     AF041129 95 
NL B ACH320     AF069524 95 
US B C15A     U84811 95 
GB B 747CD321     AJ535599 95 
FR B PIH309     AF041132 95 
US B 81GA     AY247220 95 
FR B PHI120     AF041125 95 
GB B 817CD306     AJ535619 95 
US B CC1_85_start     EF367186 95 
Summary characteristics for all analyzed sequences. Throughout this study, non-subtype 
B sequences are represented in red, assumed Haiti-originating sequences in green, 
Trinidad and Tobago-based sequences in blue and all “pandemic clade” sequences in 
gold. 
a
: indicates a non-Haitian patient annotated as being infected in Haiti or the Dominican 
Republic 
The lack of an asterisk next to a gag sequence accession number indicates that the 
sequence is restricted to the first gag dataset only. 
**: indicates a gag sequence included in both gag datasets 
*: indicates a gag sequence included only in the gag2 dataset 
H7 is underlined because the Gag sequence has three in-frame stop codons. 
Both patient IDs labeled AC_06 are bolded because they are gag sequences from the 
same patient. 
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Table 2 
SBP Analyses 
Dataset Recombination AICc 
Improvement 
Breakpoint 
Location 
Model Avg 
Support 
Gag1 Yes 57.5 221 100% 
Gag2 No N/A N/A 0% 
Env Yes 954 1738 100% 
Recombination report for the SBP analyses. SBP  was used as an initial filter for the 
identification of a single most likely breakpoint, if present, in each dataset. The goodness 
of fit of a dual- over single partition was measured via the AICc. Breakpoint location is 
relative to the segment rather than HXB2 numbering. 
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Table 3 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Recombination report from GARD analyses. GARD was employed to identify the 
approximate location of multiple recombination breakpoints in each dataset. The 
goodness of fit of the multi- over single partition model is measured by AICc. Discordant 
phylogenies were tested during the processing of GARD results using the Shimodaira and 
Hasegawa test which tests whether adjacent segments (right handed segment (RHS) vs 
left handed segment (LHS)) show a statistically significant difference in tree topologies. 
The adjusted p-values are corrected for multiple tests. Breakpoint location is relative to 
the segment rather than HXB2 numbering. 
A 
Gag Dataset 1 
Breakpoint LHS Raw p LHS adjusted p RHS Raw p RHS adjusted p 
471 0.0005 0.002 0.0001 0.0004 
812 0.0007 0.0028 0.0012 0.0048 
At p = 0.01 there are 2 significant breakpoints 
At p = 0.05 there are 2 significant breakpoints 
At p = 0.1 there are 2 significant breakpoints 
B 
Gag Dataset 2 
Breakpoint LHS Raw p LHS adjusted p RHS Raw p RHS adjusted p 
NA NA NA NA NA 
At p = 0.01 there are 0 significant breakpoints 
At p = 0.05 there are 0 significant breakpoints 
At p = 0.1 there are 0 significant breakpoints 
C 
Envelope Dataset 
Breakpoint LHS Raw p LHS adjusted p RHS Raw p RHS adjusted p 
1416 0.0009 0.0036 0.0001 0.0004 
1990 0.0001 0.0004 0.0001 0.0004 
At p = 0.01 there are 2 significant breakpoints 
At p = 0.05 there are 2 significant breakpoints 
At p = 0.1 there are 2 significant breakpoints 
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Figure 1. Majority rule consensus trees constructed before recombination detection 
analysis. Phylogenetic trees shown here depict the topology and Bayesian convergence 
results, respectively, of the gag1 (A and B) and env (C and D) datasets under the 
assumption that all input sequences are representative of a single evolutionary history. 
Again, non-subtype B sequences are represented in red, Haiti-originating sequences in 
green, Trinidad and Tobago-based sequences in blue and all non-Caribbean  sequences 
in gold (A and C). For the Bayesian convergence results (B and D), individual chains are 
colored blue or black. Posterior probabilities have been labeled on corresponding 
branches. It should be noted that upon termination of the env run, MrBayes(1) suggested 
that the analysis should be run for a greater number of generations. 
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Figure 2. Majority rule consensus trees for gag constructed after recombination detection 
analysis. Phylogenetic trees, reconstructed in MrBayes (1), depict the topology (A, C and E) and 
Bayesian convergence results (B, D and F) of GARD-inferred non-recombinant segments within 
the gag1 dataset. Trees were constructed from HXB2 positions (A) 820-1272, (C) 1273-1614 and 
(E) 1615-1952. Non-subtype B sequences are represented in red, Haiti-originating and Haiti-
linked sequences in green and all non-Caribbean subtype B sequences in gold. 
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Figure 3. Majority rule consensus trees for gag2 dataset constructed after recombination 
detection analysis. Phylogenetic trees, reconstructed in MrBayes, depict the topology (A) and 
Bayesian convergence results (B) of the non-recombinant gag2 dataset. Trees were constructed 
from HXB2 genomic positions 1198-1866. Non-subtype B sequences are represented in red, 
Haiti-originating and Haiti-linked sequences in green and all non-Caribbean subtype B 
sequences in gold.
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Figure 4. Majority rule consensus trees for env constructed after recombination detection 
analysis. Phylogenetic trees, reconstructed in MrBayes, depict the topology (A, C and E) and 
Bayesian convergence results (B, D and F) of GARD-inferred non-recombinant segments within 
the env dataset. Trees were constructed from HXB2 genomic positions (A) 6231-7406, (C) 7407-
7888 and (E) 7889-8795.Non-subtype B sequences are represented in red, Trinidad and Tobago-
based sequences in blue, Haiti-originating and Haiti-linked sequences in green and all non-
Caribbean subtype B sequences in gold. 
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Figure 5. Maximum clade credibility trees constructed using BEAST. Phylogenetic trees shown 
here depict the topology (A, B and C) of GARD-inferred non-recombinant segments within the 
gag1 dataset. Subtype C sequences were substituted for subtype D sequences as the subtype D 
sequences were clustering within the subtype B clade in trees constructed using MrBayes (1). 
Trees were constructed from HXB2 positions (A) 820-1272, (B) 1273-1614 and (C) 1615-1952. 
Non-subtype B sequences are represented in red, Haiti-originating and Haiti-linked sequences in 
green and all non-Caribbean subtype B sequences in gold. 
  
135 
 
A 
 
136 
 
B 
 
 
137 
 
C  
 
138 
 
Figure 6. Maximum clade credibility tree for the gag2 dataset constructed from the BEAST 
analysis. Trees were constructed from HXB2 positions 1198-1866. Non-subtype B sequences are 
represented in red, Haiti-originating and Haiti-linked sequences in green and all non-Caribbean 
subtype B sequences in gold. 
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Figure 7. Maximum Clade Credibility trees for the env dataset constructed from the BEAST 
analysis. Phylogenetic trees shown here depict the topology (A, B and C) of GARD-inferred non-
recombinant segments within the env dataset. Trees were constructed from HXB2 positions (A) 
6231-7406, (B) 7407-7888 and (C) 7889-8795. Non-subtype B sequences are represented in red, 
Trinidad and Tobago-based sequences in blue, Haiti-originating and Haiti-linked sequences in 
green and all non-Caribbean subtype B sequences in gold. 
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Figure 8. Distribution of UNESCO teachers by nationality recruited to the Congo region 
between 1960-1964. Data used to construct this table and chart were extracted from the 
UNESCO archival database. 
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Table 1 
Individual ALL PGlyRem Dif ALL
N
 (X) PGlyRem
N
 (Y) 
1 3.006425 1.50471 1.501716 0.022 0.011 
2 9.979484 3.580432 6.399052 0.035 0.013 
3 4.003991 1.004603 2.999388 0.023 0.012 
4 7.605062 3.026138 4.578924 0.040 0.014 
5 6.407755 2.522747 3.885008 0.013 0.006 
6 3.13315 0.911929 2.221221 0.077 0.028 
7 4.09977 2.735111 1.364659 0.015 0.007 
8 4.436364 1.891936 2.544428 0.050 0.018 
9 3.415556 1.793339 1.622217 0.022 0.011 
10 3.743879 2.114634 1.629246 0.049 0.018 
11 1.5977 0.515621 1.082079 0.058 0.029 
 
 Sum of branch lengths of ML trees for each individual reconstructed from the PGlyRem versus 
ALL dataset and the difference between them. The first set of ALL and PGlyRem values are the 
raw values from TreeRate. 
N 
The second set of ALL and PGlyRem values are the raw values normalized by the number of 
sequences in each dataset, which effectively yields an average branch length. This second set of 
values was used to in the simple linear regression. 
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Table 2 
Individual ALL (X) PGlyRem (Y) Dif 
1 3.006425 1.50471 1.501716 
2 9.979484 3.580432 6.399052 
3 4.003991 1.004603 2.999388 
4 7.605062 3.026138 4.578924 
5 6.407755 2.522747 3.885008 
6 3.13315 0.911929 2.221221 
7 4.09977 2.735111 1.364659 
8 4.436364 1.891936 2.544428 
9 3.415556 1.793339 1.622217 
10 3.743879 2.114634 1.629246 
11 1.5977 0.515621 1.082079 
 
Sum of branch lengths of ML trees for each individual reconstructed from the PGlyRem or ALL 
dataset. The difference (Dif) between the sum of branch lengths for PGlyRem and ALL is also 
shown.  
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Table 3 
 
Dataset Mean Std. Dev N 
PGlyRem 1.964 0.951 11 
ALL 4.675 2.401 11 
Dif 2.712 0.493  
    
PGlyRem
N
 0.015 0.008 11 
ALL
N
 0.037 0.020 11 
Dif
N
 0.022 0.004  
 
Descriptive statistics for the PGlyRem and ALL sum of branch lengths and the difference (DIF). 
N 
The second set of ALL, PGlyRem and Dif values are the raw values normalized by the number 
of sequences in each dataset, which effectively yields an average branch length. 
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Table 4 
 Statistic df Sig. 
Dif 0.908 11 0.231 
 
Testing normality for the paired t-test. Shapiro-Wilk test of normality using the differences 
between the normalized sum of branch lengths of PGlyRem versus ALL trees. Since the value p = 
0.231 is greater than p = 0.05, the differences, between the sum of branch lengths between the 
ALL and PGlyRem dataset, do not statistically significantly deviate from normality.  
150 
 
Table 5 
 
Stable PNGSs found in gp120 of the individuals sampled. The top part of the table represents the 
raw % conservation, which is the number of NX[ST] sequons at any given position per number 
of sequences. This is different from % identity, which would be lower for these sites, since the 
central sequon position can be highly variable and the last position can be serine or threonine. 
Sites were ranked for each individual, from 1 to 12, where 1 is the most conserved and 12 is the 
least conserved. Ties were broken by calculating the genetic distance for each site where there 
was a tie. Smaller genetic distances received the lower rank, indicating a more conserved 
position.
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Table 6 
 
Patient Mean Std. Error 
95% Wald Confidence Interval 
Lower Upper 
2 94.1478 1.49292 91.2667 97.1198 
5 97.6590 1.54860 94.6705 100.7419 
6 88.8119 1.40831 86.0941 91.6155 
7 83.0645 1.31715 80.5226 85.6866 
8 90.6778 1.54183 87.7057 93.7506 
 
Descriptive statistics for conservation of PNGSs per individual. 
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Table 7 
 
Individuals 
(I, J) 
Mean 
Difference (I-
J) 
Std. 
Error 
df 
Sequential 
Bonferroni Sig. 
95% Wald Confidence Interval 
for Difference 
Lower Upper 
2 
5 -3.5112
a
 .05568 1 0.000 -3.6675 -3.3549 
6 5.3359
a
 .08461 1 0.000 5.1013 5.5705 
7 11.0833
a
 .17577 1 0.000 10.6027 11.5639 
8 3.4700
a
 .06457 1 0.000 3.2963 3.6437 
5 
2 3.5112
a
 .05568 1 0.000 3.3549 3.6675 
6 8.8471
a
 .14029 1 0.000 8.4770 9.2172 
7 14.5945
a
 .23145 1 0.000 13.9983 15.1907 
8 6.9812
a
 .04349 1 0.000 6.8726 7.0898 
6 
2 -5.3359
a
 .08461 1 0.000 -5.5705 -5.1013 
5 -8.8471
a
 .14029 1 0.000 -9.2172 -8.4770 
7 5.7474
a
 .09116 1 0.000 5.5292 5.9656 
8 -1.8659
a
 .13966 1 0.000 -2.1789 -1.5529 
7 
2 -11.0833
a
 .17577 1 0.000 -11.5639 -10.6027 
5 -14.5945
a
 .23145 1 0.000 -15.1907 -13.9983 
6 -5.7474
a
 .09116 1 0.000 -5.9656 -5.5292 
8 -7.6133
a
 .22814 1 0.000 -8.0604 -7.1661 
8 
2 -3.4700
a
 .06457 1 0.000 -3.6437 -3.2963 
5 -6.9812
a
 .04349 1 0.000 -7.0898 -6.8726 
6 1.8659
a
 .13966 1 0.000 1.5529 2.1789 
7 7.6133
a
 .22814 1 0.000 7.1661 8.0604 
 
Conservation comparison for individuals. Pairwise comparisons of estimated marginal means 
for individuals based on the original scale of dependent variable conservation. 
a 
The  mean difference is significant at the 0.05 level. 
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Table 8 
 
Site Mean Std. Error 
95% Wald Confidence Interval 
Lower Upper 
276 97.1521 3.02652 91.3977 103.2688 
295 91.9554 2.82524 86.5814 97.6629 
301 90.9035 .00000 90.9035 90.9035 
332 92.7889 .35081 92.1039 93.4790 
339 87.6483 .00718 87.6343 87.6624 
356 97.1573 2.46384 92.4463 102.1083 
362 85.2495 .00000 85.2495 85.2495 
386 88.5089 2.26993 84.1699 93.0716 
392 96.5763 2.70295 91.4214 102.0220 
397 71.6228 .00000 71.6228 71.6228 
401 93.1493 1.43041 90.3875 95.9955 
448 98.6089 3.17706 92.5745 105.0366 
 
Descriptive statistics for conservation of PNGSs per site. 
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Table 9 
 
Site 
(I, J) 
Mean 
Difference (I-J) 
Std. 
Error 
df 
Sequential 
Bonferroni Sig. 
95% Wald Confidence Interval 
for Difference 
Lower Upper 
276 
295 5.1967
a
 .23236 1 0.000 4.4142 5.9793 
301 6.2486 3.02652 1 .662 -2.7517 15.2489 
332 4.3632 2.75496 1 1.000 -3.2590 11.9854 
339 9.5038 3.03344 1 .050 -.0032 19.0107 
356 -.0052 .99352 1 1.000 -1.9542 1.9439 
362 11.9027
a
 3.02652 1 .003 2.2270 21.5783 
386 8.6432
a
 1.35162 1 .000 4.2445 13.0419 
392 .5758 .93980 1 1.000 -1.5025 2.6541 
397 25.5293
a
 3.02652 1 0.000 15.3492 35.7094 
401 4.0028 1.67696 1 .374 -1.1154 9.1210 
448 -1.4568
a
 .43091 1 .022 -2.8157 -.0979 
295 
276 -5.1967
a
 .23236 1 0.000 -5.9793 -4.4142 
301 1.0519 2.82524 1 1.000 -4.8891 6.9928 
332 -.8335 2.54642 1 1.000 -6.1400 4.4729 
339 4.3070 2.83220 1 1.000 -3.4127 12.0268 
356 -5.2019
a
 .78423 1 .000 -7.7591 -2.6447 
362 6.7059 2.82524 1 .374 -1.8861 15.2979 
386 3.4465 1.13651 1 .065 -.0915 6.9844 
392 -4.6210
a
 .76503 1 .000 -7.1057 -2.1363 
397 20.3326
a
 2.82524 1 .000 11.1025 29.5626 
401 -1.1939 1.45777 1 1.000 -4.5680 2.1801 
448 -6.6535
a
 .44853 1 0.000 -8.1603 -5.1467 
301 
276 -6.2486 3.02652 1 .662 -15.2489 2.7517 
295 -1.0519 2.82524 1 1.000 -6.9928 4.8891 
332 -1.8854
a
 .35081 1 .000 -3.0200 -.7508 
339 3.2552
a
 .00718 1 0.000 3.2311 3.2793 
356 -6.2538 2.46384 1 .267 -13.8377 1.3301 
362 5.6541
a
 .00000 1 0.000 5.6541 5.6541 
386 2.3946 2.26993 1 1.000 -3.1504 7.9396 
392 -5.6728 2.70295 1 .645 -13.7582 2.4125 
397 19.2807
a
 .00000 1 0.000 19.2807 19.2807 
401 -2.2458 1.43041 1 1.000 -6.1905 1.6989 
448 -7.7054 3.17706 1 .352 -17.4443 2.0335 
332 
276 -4.3632 2.75496 1 1.000 -11.9854 3.2590 
295 .8335 2.54642 1 1.000 -4.4729 6.1400 
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301 1.8854
a
 .35081 1 .000 .7508 3.0200 
339 5.1406
a
 .35669 1 0.000 3.9487 6.3324 
356 -4.3684 2.13832 1 .662 -10.6928 1.9560 
362 7.5395
a
 .35081 1 0.000 6.3689 8.7100 
386 4.2800 1.93287 1 .536 -1.5637 10.1237 
392 -3.7874 2.37811 1 1.000 -10.3808 2.8059 
397 21.1661
a
 .35081 1 0.000 19.9972 22.3350 
401 -.3604 1.12248 1 1.000 -2.6966 1.9758 
448 -5.8200 2.87878 1 .662 -14.2891 2.6491 
339 
276 -9.5038 3.03344 1 .050 -19.0107 .0032 
295 -4.3070 2.83220 1 1.000 -12.0268 3.4127 
301 -3.2552
a
 .00718 1 0.000 -3.2793 -3.2311 
332 -5.1406
a
 .35669 1 0.000 -6.3324 -3.9487 
356 -9.5089
a
 2.47070 1 .004 -17.3876 -1.6303 
362 2.3989
a
 .00718 1 0.000 2.3750 2.4228 
386 -.8606 2.27664 1 1.000 -5.6534 3.9323 
392 -8.9280
a
 2.70984 1 .030 -17.4477 -.4083 
397 16.0255
a
 .00718 1 0.000 16.0017 16.0494 
401 -5.5010
a
 1.43743 1 .004 -10.0726 -.9293 
448 -10.9605
a
 3.18406 1 .018 -21.0312 -.8899 
356 
276 .0052 .99352 1 1.000 -1.9439 1.9542 
295 5.2019
a
 .78423 1 .000 2.6447 7.7591 
301 6.2538 2.46384 1 .267 -1.3301 13.8377 
332 4.3684 2.13832 1 .662 -1.9560 10.6928 
339 9.5089
a
 2.47070 1 .004 1.6303 17.3876 
362 11.9078
a
 2.46384 1 .000 3.9743 19.8413 
386 8.6484
a
 .37578 1 0.000 7.4018 9.8949 
392 .5809 .26820 1 .576 -.2258 1.3876 
397 25.5345
a
 2.46384 1 0.000 17.3739 33.6950 
401 4.0080
a
 1.04834 1 .004 .6785 7.3375 
448 -1.4516 .86096 1 1.000 -3.9602 1.0570 
362 
276 -11.9027
a
 3.02652 1 .003 -21.5783 -2.2270 
295 -6.7059 2.82524 1 .374 -15.2979 1.8861 
301 -5.6541
a
 .00000 1 0.000 -5.6541 -5.6541 
332 -7.5395
a
 .35081 1 0.000 -8.7100 -6.3689 
339 -2.3989
a
 .00718 1 0.000 -2.4228 -2.3750 
356 -11.9078
a
 2.46384 1 .000 -19.8413 -3.9743 
386 -3.2595 2.26993 1 1.000 -9.3236 2.8047 
392 -11.3269
a
 2.70295 1 .001 -19.9894 -2.6644 
397 13.6267
a
 .00000 1 0.000 13.6266 13.6267 
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401 -7.8999
a
 1.43041 1 .000 -12.5360 -3.2637 
448 -13.3594
a
 3.17706 1 .001 -23.5658 -3.1531 
386 
276 -8.6432
a
 1.35162 1 .000 -13.0419 -4.2445 
295 -3.4465 1.13651 1 .065 -6.9844 .0915 
301 -2.3946 2.26993 1 1.000 -7.9396 3.1504 
332 -4.2800 1.93287 1 .536 -10.1237 1.5637 
339 .8606 2.27664 1 1.000 -3.9323 5.6534 
356 -8.6484
a
 .37578 1 0.000 -9.8949 -7.4018 
362 3.2595 2.26993 1 1.000 -2.8047 9.3236 
392 -8.0674
a
 .52824 1 0.000 -9.8114 -6.3234 
397 16.8861
a
 2.26993 1 .000 9.4565 24.3158 
401 -4.6404
a
 .90754 1 .000 -7.5692 -1.7116 
448 -10.1000
a
 1.21345 1 .000 -14.0789 -6.1210 
392 
276 -.5758 .93980 1 1.000 -2.6541 1.5025 
295 4.6210
a
 .76503 1 .000 2.1363 7.1057 
301 5.6728 2.70295 1 .645 -2.4125 13.7582 
332 3.7874 2.37811 1 1.000 -2.8059 10.3808 
339 8.9280
a
 2.70984 1 .030 .4083 17.4477 
356 -.5809 .26820 1 .576 -1.3876 .2258 
362 11.3269
a
 2.70295 1 .001 2.6644 19.9894 
386 8.0674
a
 .52824 1 0.000 6.3234 9.8114 
397 24.9535
a
 2.70295 1 0.000 16.0444 33.8627 
401 3.4270 1.28203 1 .188 -.5347 7.3888 
448 -2.0325 .71275 1 .113 -4.2434 .1783 
397 
276 -25.5293
a
 3.02652 1 0.000 -35.7094 -15.3492 
295 -20.3326
a
 2.82524 1 .000 -29.5626 -11.1025 
301 -19.2807
a
 .00000 1 0.000 -19.2807 -19.2807 
332 -21.1661
a
 .35081 1 0.000 -22.3350 -19.9972 
339 -16.0255
a
 .00718 1 0.000 -16.0494 -16.0017 
356 -25.5345
a
 2.46384 1 0.000 -33.6950 -17.3739 
362 -13.6267
a
 .00000 1 0.000 -13.6267 -13.6266 
386 -16.8861
a
 2.26993 1 .000 -24.3158 -9.4565 
392 -24.9535
a
 2.70295 1 0.000 -33.8627 -16.0444 
401 -21.5265
a
 1.43041 1 0.000 -26.2333 -16.8197 
448 -26.9861
a
 3.17706 1 0.000 -37.4222 -16.5499 
401 
276 -4.0028 1.67696 1 .374 -9.1210 1.1154 
295 1.1939 1.45777 1 1.000 -2.1801 4.5680 
301 2.2458 1.43041 1 1.000 -1.6989 6.1905 
332 .3604 1.12248 1 1.000 -1.9758 2.6966 
339 5.5010
a
 1.43743 1 .004 .9293 10.0726 
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356 -4.0080
a
 1.04834 1 .004 -7.3375 -.6785 
362 7.8999
a
 1.43041 1 .000 3.2637 12.5360 
386 4.6404
a
 .90754 1 .000 1.7116 7.5692 
392 -3.4270 1.28203 1 .188 -7.3888 .5347 
397 21.5265
a
 1.43041 1 0.000 16.8197 26.2333 
448 -5.4596 1.76592 1 .056 -10.9758 .0567 
448 
276 1.4568
a
 .43091 1 .022 .0979 2.8157 
295 6.6535
a
 .44853 1 0.000 5.1467 8.1603 
301 7.7054 3.17706 1 .352 -2.0335 17.4443 
332 5.8200 2.87878 1 .662 -2.6491 14.2891 
339 10.9605
a
 3.18406 1 .018 .8899 21.0312 
356 1.4516 .86096 1 1.000 -1.0570 3.9602 
362 13.3594
a
 3.17706 1 .001 3.1531 23.5658 
386 10.1000
a
 1.21345 1 .000 6.1210 14.0789 
392 2.0325 .71275 1 .113 -.1783 4.2434 
397 26.9861
a
 3.17706 1 0.000 16.5499 37.4222 
401 5.4596 1.76592 1 .056 -.0567 10.9758 
 
Conservation comparison for sites. Pairwise comparisons of estimated marginal means for site 
based on the original scale of dependent variable PNGS conservation. 
a 
The  mean difference is significant at the 0.05 level. 
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Table 10 
 
Compartment Mean Std. Error 
95% Wald Confidence Interval 
Lower Upper 
PBMC 89.4518 1.59227 86.3848 92.6277 
Plasma 92.0416 1.77381 88.6298 95.5847 
 
Descriptive statistics for conservation of PNGSs per compartment 
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Table 11 
 
Compartment 
(I, J) 
Mean 
Difference (I-
J) 
Std. 
Error 
df 
Sequential 
Bonferroni Sig. 
95% Wald Confidence 
Interval for Difference
a
 
Lower Upper 
PBMC Plasma -2.5898 1.68631 1 .125 -5.8949 .7153 
Plasma PBMC 2.5898 1.68631 1 .125 -.7153 5.8949 
 
Conservation comparison for compartments. Pairwise comparisons of estimated marginal means 
for compartment based on the original scale of dependent variable Conservation 
a
Confidence interval bounds are approximate.
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Table 12 
Atom 1 Atom 2 Binding Type SeqD EucD SASD 
ASN276 LYS121 17B 82 34.8 -3 
ASN276 ILE423 17B 111 34.3 44.4 
ASN276 LYS421 17B 109 33.4 47.4 
ASN276 ARG419 17B 107 34.6 49.1 
ASN276 GLN422 17B 110 37.8 49.5 
ASN276 TYR435 17B 123 37 53.3 
ASN276 ILE420 17B 108 36.9 54 
ASN276 ALA281 B12 5 8.4 14.3 
ASN276 ASN280 B12 4 9 19.4 
ASN276 ASP474 B12 159 15.1 21.2 
ASN276 ARG456 B12 144 10.5 23.6 
ASN276 THR455 B12 143 12 23.9 
ASN276 ASP457 B12 145 14.9 24.6 
ASN276 MET475 B12 160 20.2 27.1 
ASN276 SER365 B12 67 19.7 27.3 
ASN276 ILE371 B12 73 19.9 29.1 
ASN276 VAL430 B12 118 24.8 30 
ASN276 SER364 B12 66 21.2 30.9 
ASN276 ASP368 B12 70 24.2 31 
ASN276 PRO470 B12 155 19.1 32.6 
ASN276 GLU370 B12 72 24 32.7 
ASN276 VAL372 B12 74 24.4 33.2 
ASN276 THR257 B12 19 21.2 33.5 
ASN276 LEU453 B12 141 15.6 35.9 
ASN276 PRO369 B12 71 27.7 36.8 
ASN276 THR373 B12 75 26.8 37.8 
ASN276 SER256 B12 20 23.8 39.2 
ASN276 TYR384 B12 86 30.1 40.7 
ASN276 ASN386 B12 88 30.1 41.4 
ASN276 LYS432 B12 120 31.6 42.8 
ASN276 ARG419 B12 107 34.6 45.5 
ASN276 CYS418 B12 106 33.7 46 
ASN276 PRO417 B12 105 34.7 47.1 
ASN276 THR123 CCR5 80 31.4 36.8 
ASN276 LYS121 CCR5 82 34.8 43 
ASN276 ARG419 CCR5 107 34.6 49.1 
ASN276 LYS421 CCR5 109 33.4 50.1 
ASN276 GLN422 CCR5 110 37.8 51 
ASN276 ILE420 CCR5 108 36.9 54 
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ASN276 LYS117 CCR5 86 38.8 56.2 
ASN276 PRO437 CCR5 125 43.4 57.4 
ASN276 PRO438 CCR5 126 40.7 57.8 
ASN276 HIS330 CCR5 32 37.1 60.1 
ASN276 LYS207 CCR5 69 42 67.5 
ASN276 ARG440 CCR5 128 47.7 68.5 
ASN276 ARG444 CCR5 132 39.6 72.7 
ASN276 ASN279 CD4 3 3.6 4 
ASN276 LYS282 CD4 6 4.7 5.9 
ASN276 ALA281 CD4 5 8.4 9.4 
ASN276 ASN280 CD4 4 9 10.2 
ASN276 THR283 CD4 7 10.2 12 
ASN276 ARG456 CD4 144 10.5 13.7 
ASN276 THR455 CD4 143 12 14.9 
ASN276 ASP477 CD4 162 14 15.4 
ASN276 ASP474 CD4 159 15.1 15.9 
ASN276 ASP457 CD4 145 14.9 16.8 
ASN276 ARG476 CD4 161 16 17.8 
ASN276 ARG469 CD4 154 17.3 20.1 
ASN276 MET475 CD4 160 20.2 21.3 
ASN276 ILE371 CD4 73 19.9 22 
ASN276 SER365 CD4 67 19.7 22.6 
ASN276 TRP427 CD4 115 23.3 25.3 
ASN276 GLU370 CD4 72 24 26.2 
ASN276 ASP368 CD4 70 24.2 26.4 
ASN276 GLN428 CD4 116 26.3 28 
ASN276 VAL430 CD4 118 24.8 28.7 
ASN276 SER375 CD4 77 25.9 28.9 
ASN276 GLU429 CD4 117 26.1 29 
ASN276 ASN425 CD4 113 26.6 29.6 
ASN276 MET426 CD4 114 27.7 31 
ASN276 LYS432 CD4 120 31.6 36 
ASN276 THR123 CG10 80 31.4 36.8 
ASN276 LYS432 CG10 120 31.6 42.8 
ASN276 LYS121 CG10 82 34.8 43 
ASN276 ILE423 CG10 111 34.3 44.4 
ASN276 LYS421 CG10 109 33.4 47.4 
ASN276 GLN422 CG10 110 37.8 49.5 
ASN276 MET434 CG10 122 37.4 49.6 
ASN276 TYR435 CG10 123 37 52.8 
ASN276 LYS207 CG10 69 42 62.2 
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ASN295 LYS121 17B 101 31.4 -3 
ASN295 ARG419 17B 88 16.9 34.2 
ASN295 ILE420 17B 89 16 39.5 
ASN295 LYS421 17B 90 19.9 40.4 
ASN295 GLN422 17B 91 23.4 44.8 
ASN295 ILE423 17B 92 25.7 45.1 
ASN295 TYR435 17B 104 23.2 49.5 
ASN295 PRO417 B12 86 14.5 24.8 
ASN295 CYS418 B12 87 11.5 28 
ASN295 ASN386 B12 69 16.2 29.5 
ASN295 ARG419 B12 88 16.9 31.4 
ASN295 TYR384 B12 67 16.6 33.9 
ASN295 THR373 B12 56 17.3 34.2 
ASN295 SER256 B12 39 15 35.7 
ASN295 VAL372 B12 55 22.1 38.3 
ASN295 PRO369 B12 52 21.8 39.4 
ASN295 SER364 B12 47 22.6 40.6 
ASN295 THR257 B12 38 18.5 41.3 
ASN295 GLU370 B12 53 21.6 42.1 
ASN295 ILE371 B12 54 22.9 43.4 
ASN295 PRO470 B12 136 19.9 44 
ASN295 ASP368 B12 51 25.6 45.2 
ASN295 SER365 B12 48 28.1 45.5 
ASN295 LEU453 B12 122 20.9 45.8 
ASN295 THR455 B12 124 27 51.9 
ASN295 LYS432 B12 101 29.4 54.4 
ASN295 ASP457 B12 126 31.6 54.9 
ASN295 VAL430 B12 99 32.8 55.6 
ASN295 ASP474 B12 140 27.2 56.1 
ASN295 ARG456 B12 125 30.2 57.1 
ASN295 ALA281 B12 14 34.1 57.2 
ASN295 ASN280 B12 15 33.7 57.5 
ASN295 MET475 B12 141 23.7 58.9 
ASN295 LYS121 CCR5 101 31.4 -3 
ASN295 ARG444 CCR5 113 7.2 19 
ASN295 HIS330 CCR5 13 9.4 20.1 
ASN295 ARG440 CCR5 109 20 30.8 
ASN295 LYS207 CCR5 88 21.7 33.7 
ASN295 ARG419 CCR5 88 16.9 34.2 
ASN295 ILE420 CCR5 89 16 39.5 
ASN295 LYS421 CCR5 90 19.9 40.4 
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ASN295 PRO437 CCR5 106 23.5 41.3 
ASN295 PRO438 CCR5 107 18.1 43.3 
ASN295 GLN422 CCR5 91 23.4 44.8 
ASN295 LYS117 CCR5 105 28.2 44.8 
ASN295 THR123 CCR5 99 35.1 68.1 
ASN295 SER365 CD4 48 28.1 47.6 
ASN295 ASN425 CD4 94 25.6 49.9 
ASN295 ARG469 CD4 135 24.8 50.3 
ASN295 ASP368 CD4 51 25.6 50.7 
ASN295 LYS432 CD4 101 29.4 53.7 
ASN295 GLU370 CD4 53 21.6 54.2 
ASN295 ASP457 CD4 126 31.6 55.3 
ASN295 ILE371 CD4 54 22.9 55.7 
ASN295 THR455 CD4 124 27 56.4 
ASN295 MET426 CD4 95 27.2 56.7 
ASN295 SER375 CD4 58 17.1 57 
ASN295 TRP427 CD4 96 24.2 58.8 
ASN295 ARG456 CD4 125 30.2 59 
ASN295 VAL430 CD4 99 32.8 59 
ASN295 ALA281 CD4 14 34.1 59.6 
ASN295 ASN280 CD4 15 33.7 60.1 
ASN295 THR283 CD4 12 26.7 60.7 
ASN295 GLN428 CD4 97 28.2 61.8 
ASN295 GLU429 CD4 98 31.9 62.1 
ASN295 MET475 CD4 141 23.7 63.4 
ASN295 LYS282 CD4 13 32.2 64.4 
ASN295 ASP474 CD4 140 27.2 64.9 
ASN295 ASP477 CD4 143 24.7 65.9 
ASN295 ASN279 CD4 16 36 66 
ASN295 ARG476 CD4 142 28.1 68.9 
ASN295 LYS121 CG10 101 31.4 -3 
ASN295 LYS207 CG10 88 21.7 33.7 
ASN295 TYR435 CG10 104 23.2 42.1 
ASN295 LYS421 CG10 90 19.9 42.5 
ASN295 GLN422 CG10 91 23.4 44.8 
ASN295 ILE423 CG10 92 25.7 45.1 
ASN295 MET434 CG10 103 27.9 48.3 
ASN295 LYS432 CG10 101 29.4 51 
ASN295 THR123 CG10 99 35.1 68.1 
ASN301 LYS121 17B 107 30.8 -3 
ASN301 ARG419 17B 82 15.3 24.8 
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ASN301 GLN422 17B 85 18.8 27.4 
ASN301 LYS421 17B 84 18.5 29 
ASN301 ILE423 17B 86 23 30.9 
ASN301 ILE420 17B 83 13.1 31.1 
ASN301 TYR435 17B 98 20.9 33.8 
ASN301 PRO417 B12 80 15.9 18.5 
ASN301 CYS418 B12 81 14.3 22 
ASN301 ARG419 B12 82 15.3 23.4 
ASN301 ASN386 B12 63 20.1 24.3 
ASN301 TYR384 B12 61 19 27.5 
ASN301 THR373 B12 50 22.2 28.2 
ASN301 VAL372 B12 49 26.6 31.4 
ASN301 PRO369 B12 46 23.9 31.7 
ASN301 GLU370 B12 47 26.4 35.1 
ASN301 SER364 B12 41 29.4 35.6 
ASN301 THR257 B12 44 27.1 36.6 
ASN301 ILE371 B12 48 29.6 36.8 
ASN301 PRO470 B12 130 29.8 37.7 
ASN301 ASP368 B12 45 28.9 37.8 
ASN301 LYS432 B12 95 28.8 38.1 
ASN301 SER365 B12 42 34.4 40.5 
ASN301 SER256 B12 45 25.6 41.3 
ASN301 LEU453 B12 116 32.6 43.9 
ASN301 THR455 B12 118 37.2 44.8 
ASN301 VAL430 B12 93 36.1 48.3 
ASN301 ARG456 B12 119 41.3 48.5 
ASN301 ASP457 B12 120 40.7 48.7 
ASN301 ASP474 B12 134 36.2 49.1 
ASN301 ASN280 B12 21 43.9 51.5 
ASN301 ALA281 B12 20 43.4 52.2 
ASN301 MET475 B12 135 32.5 52.8 
ASN301 ARG440 CCR5 103 10.4 11.4 
ASN301 HIS330 CCR5 7 12.2 14.8 
ASN301 PRO437 CCR5 100 15.1 16.9 
ASN301 PRO438 CCR5 101 11.9 18.7 
ASN301 LYS207 CCR5 94 18.7 22.6 
ASN301 ARG444 CCR5 107 13.1 23.3 
ASN301 GLN422 CCR5 85 18.8 23.4 
ASN301 ILE420 CCR5 83 13.1 23.5 
ASN301 ARG419 CCR5 82 15.3 24.1 
ASN301 LYS421 CCR5 84 18.5 27.4 
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ASN301 LYS117 CCR5 111 27.5 37.1 
ASN301 THR123 CCR5 105 36 54.2 
ASN301 LYS121 CCR5 107 30.8 61.7 
ASN301 ASN425 CD4 88 27.9 38.1 
ASN301 LYS432 CD4 95 28.8 38.1 
ASN301 ASP368 CD4 45 28.9 40.1 
ASN301 GLU370 CD4 47 26.4 41.9 
ASN301 MET426 CD4 89 30 43.4 
ASN301 SER365 CD4 42 34.4 43.5 
ASN301 SER375 CD4 52 23 44.3 
ASN301 TRP427 CD4 90 30.3 45.9 
ASN301 ILE371 CD4 48 29.6 46.8 
ASN301 VAL430 CD4 93 36.1 47.4 
ASN301 ARG469 CD4 129 33.9 47.9 
ASN301 GLN428 CD4 91 33.1 48.5 
ASN301 GLU429 CD4 92 35.8 48.5 
ASN301 ASP457 CD4 120 40.7 50.8 
ASN301 MET475 CD4 135 32.5 51.1 
ASN301 ASP474 CD4 134 36.2 52.6 
ASN301 THR455 CD4 118 37.2 52.8 
ASN301 ARG456 CD4 119 41.3 55.1 
ASN301 ASN280 CD4 21 43.9 55.8 
ASN301 ALA281 CD4 20 43.4 56.8 
ASN301 ASP477 CD4 137 36 56.9 
ASN301 ARG476 CD4 136 38.2 56.9 
ASN301 THR283 CD4 18 37.9 57.2 
ASN301 LYS282 CD4 19 43.4 61.2 
ASN301 ASN279 CD4 22 47 61.5 
ASN301 LYS207 CG10 94 18.7 24.5 
ASN301 GLN422 CG10 85 18.8 27.4 
ASN301 LYS421 CG10 84 18.5 29 
ASN301 ILE423 CG10 86 23 30.9 
ASN301 MET434 CG10 97 24.3 31.9 
ASN301 TYR435 CG10 98 20.9 33 
ASN301 LYS432 CG10 95 28.8 36.8 
ASN301 LYS121 CG10 107 30.8 38.5 
ASN301 THR123 CG10 105 36 46.2 
ASN332 LYS121 17B 116 33.3 -3 
ASN332 ARG419 17B 73 15.9 29.7 
ASN332 ILE420 17B 74 16.7 35.7 
ASN332 LYS421 17B 75 20.2 35.9 
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ASN332 ILE423 17B 77 26.1 41.5 
ASN332 GLN422 17B 76 24.2 41.6 
ASN332 TYR435 17B 89 25.1 44.7 
ASN332 PRO417 B12 71 11.4 22.9 
ASN332 CYS418 B12 72 10.6 26.2 
ASN332 ASN386 B12 54 13.8 28.3 
ASN332 ARG419 B12 73 15.9 28.4 
ASN332 TYR384 B12 52 16.3 32 
ASN332 THR373 B12 41 16.2 32.8 
ASN332 PRO369 B12 37 21.1 36.3 
ASN332 SER256 B12 54 17 37 
ASN332 VAL372 B12 40 20.8 37.2 
ASN332 SER364 B12 32 21 39.7 
ASN332 GLU370 B12 38 22 40.7 
ASN332 ILE371 B12 39 22.7 41.3 
ASN332 ASP368 B12 36 25.4 42 
ASN332 THR257 B12 53 19.2 42.5 
ASN332 PRO470 B12 121 18.8 42.9 
ASN332 SER365 B12 33 26.3 43.8 
ASN332 LEU453 B12 107 21.5 48.4 
ASN332 THR455 B12 109 26.4 49.9 
ASN332 LYS432 B12 86 30.3 51.8 
ASN332 ASP457 B12 111 29.8 52.4 
ASN332 VAL430 B12 84 33.9 53.8 
ASN332 ASP474 B12 125 28.4 54.1 
ASN332 ARG456 B12 110 29.2 56.3 
ASN332 ALA281 B12 29 33.8 56.3 
ASN332 ASN280 B12 30 32.8 57 
ASN332 MET475 B12 126 25.8 57.2 
ASN332 HIS330 CCR5 2 7 7.3 
ASN332 ARG419 CCR5 73 15.9 20.8 
ASN332 ARG444 CCR5 98 10.8 21.5 
ASN332 ILE420 CCR5 74 16.7 26.8 
ASN332 LYS421 CCR5 75 20.2 27 
ASN332 ARG440 CCR5 94 22 29.8 
ASN332 PRO438 CCR5 92 19.3 30.8 
ASN332 GLN422 CCR5 76 24.2 32.7 
ASN332 PRO437 CCR5 91 24.6 34.7 
ASN332 LYS207 CCR5 103 24.7 34.8 
ASN332 LYS117 CCR5 120 31.2 44.3 
ASN332 THR123 CCR5 114 36.7 54.9 
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ASN332 LYS121 CCR5 116 33.3 62.7 
ASN332 SER365 CD4 33 26.3 45.2 
ASN332 ASP368 CD4 36 25.4 47.8 
ASN332 ARG469 CD4 120 23.2 49.6 
ASN332 ASN425 CD4 79 26.2 51.1 
ASN332 ASP457 CD4 111 29.8 52.4 
ASN332 LYS432 CD4 86 30.3 52.5 
ASN332 GLU370 CD4 38 22 52.8 
ASN332 ILE371 CD4 39 22.7 54.4 
ASN332 THR455 CD4 109 26.4 54.9 
ASN332 SER375 CD4 43 17.7 55.7 
ASN332 ARG456 CD4 110 29.2 56.9 
ASN332 MET426 CD4 80 28.8 57.4 
ASN332 ASN280 CD4 30 32.8 57.8 
ASN332 VAL430 CD4 84 33.9 58 
ASN332 TRP427 CD4 81 26 58.1 
ASN332 ALA281 CD4 29 33.8 58.5 
ASN332 THR283 CD4 27 27.2 59.6 
ASN332 GLU429 CD4 83 33.7 61.6 
ASN332 GLN428 CD4 82 30.5 62.1 
ASN332 ASP474 CD4 125 28.4 62.8 
ASN332 MET475 CD4 126 25.8 63 
ASN332 ASN279 CD4 31 35.9 63.2 
ASN332 LYS282 CD4 28 32.4 63.3 
ASN332 ASP477 CD4 128 26.2 64.8 
ASN332 ARG476 CD4 127 30.1 67.4 
ASN332 LYS207 CG10 103 24.7 34.8 
ASN332 LYS421 CG10 75 20.2 40.8 
ASN332 TYR435 CG10 89 25.1 41.5 
ASN332 GLN422 CG10 76 24.2 42.8 
ASN332 ILE423 CG10 77 26.1 43 
ASN332 MET434 CG10 88 29.2 47.1 
ASN332 LYS432 CG10 86 30.3 48.8 
ASN332 THR123 CG10 114 36.7 64.4 
ASN332 LYS121 CG10 116 33.3 72.2 
ASN356 LYS121 17B 140 50.1 -3 
ASN356 ARG419 17B 49 40.6 50.1 
ASN356 LYS421 17B 51 42.5 54.7 
ASN356 ILE423 17B 53 45.4 55.9 
ASN356 ILE420 17B 50 44.6 56.6 
ASN356 GLN422 17B 52 48 60.3 
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ASN356 TYR435 17B 65 48.9 63.5 
ASN356 ASN280 B12 54 17.8 22.4 
ASN356 ASP457 B12 87 17.1 24.1 
ASN356 ARG456 B12 86 16 25.9 
ASN356 ALA281 B12 53 23.2 27.3 
ASN356 THR455 B12 85 21.2 29.9 
ASN356 SER365 B12 9 25 32.3 
ASN356 SER364 B12 8 26.8 37.1 
ASN356 ILE371 B12 15 30.3 38.8 
ASN356 VAL372 B12 16 31.4 40.1 
ASN356 PRO470 B12 97 24.7 40.4 
ASN356 ASP474 B12 101 31.6 40.7 
ASN356 THR257 B12 77 31.5 43.6 
ASN356 ASP368 B12 12 35.3 44 
ASN356 ASN386 B12 30 33.2 44.2 
ASN356 GLU370 B12 14 35.2 44.3 
ASN356 PRO417 B12 47 36.7 44.5 
ASN356 THR373 B12 17 33.2 44.8 
ASN356 MET475 B12 102 35.6 44.8 
ASN356 LEU453 B12 83 26.1 46.2 
ASN356 PRO369 B12 13 36.2 46.2 
ASN356 VAL430 B12 60 41.1 47.6 
ASN356 TYR384 B12 28 37.6 48.9 
ASN356 SER256 B12 78 33.8 49.3 
ASN356 ARG419 B12 49 40.6 50.1 
ASN356 CYS418 B12 48 38.6 50.8 
ASN356 LYS432 B12 62 45 55.3 
ASN356 ARG419 CCR5 49 40.6 50.1 
ASN356 HIS330 CCR5 26 39.5 51.3 
ASN356 LYS421 CCR5 51 42.5 54.7 
ASN356 ILE420 CCR5 50 44.6 56.6 
ASN356 THR123 CCR5 138 47.9 57.5 
ASN356 GLN422 CCR5 52 48 60.8 
ASN356 PRO438 CCR5 68 49 60.8 
ASN356 PRO437 CCR5 67 52.8 65 
ASN356 LYS121 CCR5 140 50.1 65.4 
ASN356 ARG444 CCR5 74 45.1 66.1 
ASN356 ARG440 CCR5 70 55.5 71.4 
ASN356 LYS207 CCR5 127 53.2 75.4 
ASN356 LYS117 CCR5 144 53.3 79.9 
ASN356 ASN280 CD4 54 17.8 22.4 
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ASN356 ASP457 CD4 87 17.1 24.1 
ASN356 ARG456 CD4 86 16 25.9 
ASN356 ASN279 CD4 55 20.4 26.4 
ASN356 ALA281 CD4 53 23.2 27.3 
ASN356 LYS282 CD4 52 22.1 28.9 
ASN356 THR455 CD4 85 21.2 29.9 
ASN356 ARG469 CD4 96 21.2 30.7 
ASN356 SER365 CD4 9 25 32.3 
ASN356 THR283 CD4 51 24.3 32.9 
ASN356 ASP477 CD4 104 29.1 37.9 
ASN356 ILE371 CD4 15 30.3 38.8 
ASN356 ASP474 CD4 101 31.6 40.4 
ASN356 ARG476 CD4 103 33.7 42.4 
ASN356 ASP368 CD4 12 35.3 44 
ASN356 GLU370 CD4 14 35.2 44.3 
ASN356 MET475 CD4 102 35.6 44.7 
ASN356 SER375 CD4 19 35.4 47.1 
ASN356 VAL430 CD4 60 41.1 47.6 
ASN356 ASN425 CD4 55 39.3 47.8 
ASN356 TRP427 CD4 57 38.1 48.4 
ASN356 MET426 CD4 56 42.6 52.1 
ASN356 GLU429 CD4 59 43.3 52.1 
ASN356 GLN428 CD4 58 42.8 52.4 
ASN356 LYS432 CD4 62 45 54.1 
ASN356 ILE423 CG10 53 45.4 55.9 
ASN356 LYS432 CG10 62 45 56.3 
ASN356 LYS421 CG10 51 42.5 57.4 
ASN356 THR123 CG10 138 47.9 57.5 
ASN356 GLN422 CG10 52 48 60.3 
ASN356 MET434 CG10 64 49.9 62.4 
ASN356 LYS121 CG10 140 50.1 62.5 
ASN356 TYR435 CG10 65 48.9 63.9 
ASN356 LYS207 CG10 127 53.2 73.5 
ASN362 LYS121 17B 146 34 -3 
ASN362 ARG419 17B 43 21.5 27 
ASN362 LYS421 17B 45 23.8 30.9 
ASN362 ILE420 17B 44 26.3 32.5 
ASN362 ILE423 17B 47 26.9 33.3 
ASN362 GLN422 17B 46 29.4 36.6 
ASN362 TYR435 17B 59 31.4 39.7 
ASN362 SER365 B12 3 8.2 13.7 
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ASN362 ASP457 B12 81 8.3 17 
ASN362 SER364 B12 2 8.4 17.4 
ASN362 VAL372 B12 10 12.6 18.7 
ASN362 ASN386 B12 24 14.1 19.7 
ASN362 THR373 B12 11 14.6 21.2 
ASN362 PRO470 B12 91 8.7 21.5 
ASN362 THR455 B12 79 10.5 22.5 
ASN362 ILE371 B12 9 14 22.5 
ASN362 PRO369 B12 7 17.4 22.6 
ASN362 ARG456 B12 80 11 23.4 
ASN362 ASN280 B12 60 13.6 23.7 
ASN362 ASP368 B12 6 18 24.7 
ASN362 PRO417 B12 41 18.2 24.7 
ASN362 TYR384 B12 22 19 24.9 
ASN362 ALA281 B12 59 16.7 25.2 
ASN362 GLU370 B12 8 18.3 25.2 
ASN362 THR257 B12 83 16.1 26.9 
ASN362 ARG419 B12 43 21.5 27 
ASN362 CYS418 B12 42 20.7 27.6 
ASN362 LEU453 B12 77 14.8 28.8 
ASN362 ASP474 B12 95 20.7 31.5 
ASN362 SER256 B12 84 19.9 32.5 
ASN362 VAL430 B12 54 26.9 34.4 
ASN362 MET475 B12 96 23.5 36.3 
ASN362 LYS432 B12 56 27.9 40.1 
ASN362 ARG419 CCR5 43 21.5 27 
ASN362 LYS421 CCR5 45 23.8 30.9 
ASN362 HIS330 CCR5 32 22.5 31.1 
ASN362 ILE420 CCR5 44 26.3 32.5 
ASN362 GLN422 CCR5 46 29.4 36.6 
ASN362 PRO438 CCR5 62 30.8 37.6 
ASN362 PRO437 CCR5 61 34.1 41.9 
ASN362 THR123 CCR5 144 33 45.4 
ASN362 LYS121 CCR5 146 34 51.7 
ASN362 LYS207 CCR5 133 36.4 51.8 
ASN362 ARG440 CCR5 64 37.9 51.8 
ASN362 ARG444 CCR5 68 30 54.1 
ASN362 LYS117 CCR5 150 37.5 62.6 
ASN362 ARG469 CD4 90 5.2 5.2 
ASN362 SER365 CD4 3 8.2 8.3 
ASN362 ASP457 CD4 81 8.3 9.7 
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ASN362 THR455 CD4 79 10.5 11 
ASN362 ARG456 CD4 80 11 12.8 
ASN362 ASN280 CD4 60 13.6 14.9 
ASN362 ILE371 CD4 9 14 16.1 
ASN362 THR283 CD4 57 15.8 16.7 
ASN362 ALA281 CD4 59 16.7 17 
ASN362 LYS282 CD4 58 17.9 19.4 
ASN362 ASN279 CD4 61 19 19.7 
ASN362 ASP368 CD4 6 18 21.2 
ASN362 GLU370 CD4 8 18.3 21.6 
ASN362 ASP477 CD4 98 19.8 21.6 
ASN362 ASP474 CD4 95 20.7 22.1 
ASN362 SER375 CD4 13 18.3 23.8 
ASN362 ASN425 CD4 49 22.4 25.5 
ASN362 ARG476 CD4 97 24.7 26.2 
ASN362 MET475 CD4 96 23.5 27 
ASN362 TRP427 CD4 51 23.8 27.3 
ASN362 VAL430 CD4 54 26.9 29.7 
ASN362 MET426 CD4 50 27.2 30.9 
ASN362 LYS432 CD4 56 27.9 31.1 
ASN362 GLN428 CD4 52 29.2 32.3 
ASN362 GLU429 CD4 53 29.7 32.4 
ASN362 ILE423 CG10 47 26.9 33.3 
ASN362 LYS421 CG10 45 23.8 34.1 
ASN362 GLN422 CG10 46 29.4 36.7 
ASN362 LYS432 CG10 56 27.9 36.9 
ASN362 MET434 CG10 58 32 38.6 
ASN362 TYR435 CG10 59 31.4 41.3 
ASN362 LYS121 CG10 146 34 44.9 
ASN362 THR123 CG10 144 33 45.4 
ASN362 LYS207 CG10 133 36.4 51.1 
ASN386 LYS121 17B 170 26.2 -3 
ASN386 ARG419 17B 19 7.9 8.9 
ASN386 LYS421 17B 21 12.1 13.4 
ASN386 ILE420 17B 20 13 15.1 
ASN386 ILE423 17B 23 17 18.9 
ASN386 GLN422 17B 22 17.6 19.5 
ASN386 TYR435 17B 35 20.3 22.1 
ASN386 ASN386 B12 0 0 0 
ASN386 THR373 B12 13 5.1 5.1 
ASN386 PRO417 B12 17 4.9 5.8 
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ASN386 CYS418 B12 18 7.4 7.4 
ASN386 TYR384 B12 2 7.4 8 
ASN386 VAL372 B12 14 8.3 8.3 
ASN386 ARG419 B12 19 7.9 8.9 
ASN386 PRO369 B12 17 9.3 9.3 
ASN386 SER364 B12 22 9.7 11 
ASN386 GLU370 B12 16 12.5 12.5 
ASN386 ILE371 B12 15 12.6 12.8 
ASN386 PRO470 B12 67 11.1 14.1 
ASN386 THR257 B12 107 12.3 14.3 
ASN386 ASP368 B12 18 14 14.8 
ASN386 SER365 B12 21 14.6 16.4 
ASN386 SER256 B12 108 14.5 19.5 
ASN386 LEU453 B12 53 16.6 20.2 
ASN386 THR455 B12 55 18.3 20.9 
ASN386 VAL430 B12 30 24.2 25.1 
ASN386 ASP457 B12 57 20.7 25.2 
ASN386 ASP474 B12 71 21.5 25.8 
ASN386 ASN280 B12 84 24.5 26.9 
ASN386 ARG456 B12 56 22.1 27.1 
ASN386 ALA281 B12 83 24.8 27.6 
ASN386 LYS432 B12 32 20.6 28.1 
ASN386 MET475 B12 72 20.9 29.8 
ASN386 ARG419 CCR5 19 7.9 8.9 
ASN386 LYS421 CCR5 21 12.1 13.4 
ASN386 ILE420 CCR5 20 13 15.1 
ASN386 HIS330 CCR5 56 9.9 17.5 
ASN386 PRO438 CCR5 38 17.4 19.5 
ASN386 GLN422 CCR5 22 17.6 19.5 
ASN386 PRO437 CCR5 37 21 23.4 
ASN386 ARG440 CCR5 40 24.2 32.8 
ASN386 LYS207 CCR5 157 24.4 33.7 
ASN386 THR123 CCR5 168 27.9 38.1 
ASN386 ARG444 CCR5 44 18.4 40.6 
ASN386 LYS121 CCR5 170 26.2 46.2 
ASN386 LYS117 CCR5 174 27.8 49.8 
ASN386 SER365 CD4 21 14.6 20.1 
ASN386 ASP368 CD4 18 14 20.4 
ASN386 ARG469 CD4 66 14.2 22.2 
ASN386 ASN425 CD4 25 16.3 22.8 
ASN386 GLU370 CD4 16 12.5 24.9 
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ASN386 ILE371 CD4 15 12.6 25.4 
ASN386 LYS432 CD4 32 20.6 26.1 
ASN386 ASP457 CD4 57 20.7 27.3 
ASN386 THR455 CD4 55 18.3 27.9 
ASN386 SER375 CD4 11 10.3 28.2 
ASN386 MET426 CD4 26 21.1 29.1 
ASN386 VAL430 CD4 30 24.2 29.5 
ASN386 TRP427 CD4 27 19.3 31 
ASN386 ASN280 CD4 84 24.5 31.4 
ASN386 ARG456 CD4 56 22.1 31.5 
ASN386 ALA281 CD4 83 24.8 31.9 
ASN386 THR283 CD4 81 20.8 32.6 
ASN386 GLU429 CD4 29 25.9 34.5 
ASN386 GLN428 CD4 28 24.4 34.6 
ASN386 ASP474 CD4 71 21.5 34.7 
ASN386 MET475 CD4 72 20.9 34.9 
ASN386 LYS282 CD4 82 25.6 36.3 
ASN386 ASN279 CD4 85 28.4 37.6 
ASN386 ASP477 CD4 74 21.3 37.7 
ASN386 ARG476 CD4 73 25.1 39 
ASN386 LYS421 CG10 21 12.1 18.1 
ASN386 ILE423 CG10 23 17 19.8 
ASN386 GLN422 CG10 22 17.6 20.9 
ASN386 LYS432 CG10 32 20.6 24.2 
ASN386 TYR435 CG10 35 20.3 25.4 
ASN386 MET434 CG10 34 21.9 25.4 
ASN386 LYS121 CG10 170 26.2 31.9 
ASN386 LYS207 CG10 157 24.4 34 
ASN386 THR123 CG10 168 27.9 35.4 
ASN448 LYS121 17B 218 31.1 -3 
ASN448 ARG419 17B 29 22.4 50.3 
ASN448 LYS421 17B 27 23.4 56.5 
ASN448 ILE420 17B 28 21.6 56.9 
ASN448 GLN422 17B 26 27.3 58.4 
ASN448 ILE423 17B 25 28.2 60.6 
ASN448 TYR435 17B 13 25.5 62.4 
ASN448 SER256 B12 156 11.5 25.7 
ASN448 THR257 B12 155 16.2 31.1 
ASN448 GLU370 B12 64 20.9 34.7 
ASN448 LEU453 B12 5 15.4 36.7 
ASN448 ILE371 B12 63 21.2 36.8 
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ASN448 THR373 B12 61 19.3 37.7 
ASN448 PRO470 B12 19 17.8 38 
ASN448 PRO369 B12 65 23.6 38.5 
ASN448 ASP368 B12 66 25.4 38.9 
ASN448 VAL372 B12 62 23 39.8 
ASN448 TYR384 B12 50 19.8 40.1 
ASN448 SER364 B12 70 22.2 40.7 
ASN448 PRO417 B12 31 21.2 42.3 
ASN448 ASN386 B12 48 20.4 43.6 
ASN448 ARG419 B12 29 22.4 44.3 
ASN448 SER365 B12 69 27.2 44.9 
ASN448 CYS418 B12 30 17.7 45.5 
ASN448 ASP474 B12 23 21.7 45.9 
ASN448 VAL430 B12 18 30.5 46 
ASN448 THR455 B12 7 22.8 47.3 
ASN448 MET475 B12 24 18.4 48.1 
ASN448 ALA281 B12 131 29 51.2 
ASN448 ARG456 B12 8 25.5 53 
ASN448 ASN280 B12 132 29 53.9 
ASN448 ASP457 B12 9 28.6 54 
ASN448 LYS432 B12 16 30 54.4 
ASN448 ARG444 CCR5 4 14.9 24 
ASN448 LYS207 CCR5 205 24.9 33.6 
ASN448 ARG440 CCR5 8 27.1 37 
ASN448 HIS330 CCR5 104 18.1 38.2 
ASN448 PRO437 CCR5 11 29 44 
ASN448 LYS117 CCR5 222 28.3 45.7 
ASN448 PRO438 CCR5 10 24 47 
ASN448 GLN422 CCR5 26 27.3 50.2 
ASN448 ARG419 CCR5 29 22.4 50.3 
ASN448 ILE420 CCR5 28 21.6 51.1 
ASN448 LYS421 CCR5 27 23.4 55.1 
ASN448 THR123 CCR5 216 33.6 68.8 
ASN448 LYS121 CCR5 218 31.1 72.3 
ASN448 SER365 CD4 69 27.2 63.2 
ASN448 ASP457 CD4 9 28.6 64.6 
ASN448 ASN279 CD4 133 29.7 65 
ASN448 ASN280 CD4 132 29 65.8 
ASN448 ARG469 CD4 18 22.7 67.4 
ASN448 LYS432 CD4 16 30 67.4 
ASN448 GLN428 CD4 20 24.8 67.6 
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ASN448 LYS282 CD4 130 25.7 67.8 
ASN448 GLU429 CD4 19 28.8 68 
ASN448 ASP368 CD4 66 25.4 68.1 
ASN448 ASN425 CD4 23 25.3 69 
ASN448 ARG456 CD4 8 25.5 69.8 
ASN448 MET426 CD4 22 25.6 69.9 
ASN448 ALA281 CD4 131 29 70.1 
ASN448 THR455 CD4 7 22.8 71.4 
ASN448 GLU370 CD4 64 20.9 71.5 
ASN448 ILE371 CD4 63 21.2 72.6 
ASN448 TRP427 CD4 21 21.1 73.8 
ASN448 THR283 CD4 129 20.7 74.4 
ASN448 VAL430 CD4 18 30.5 74.9 
ASN448 SER375 CD4 59 17.3 75.4 
ASN448 MET475 CD4 24 18.4 76.4 
ASN448 ASP474 CD4 23 21.7 77.3 
ASN448 ARG476 CD4 25 21.2 78 
ASN448 ASP477 CD4 26 17.9 78.6 
ASN448 LYS207 CG10 205 24.9 33.6 
ASN448 TYR435 CG10 13 25.5 42.6 
ASN448 GLN422 CG10 26 27.3 47.3 
ASN448 MET434 CG10 14 30.1 47.9 
ASN448 ILE423 CG10 25 28.2 50.3 
ASN448 LYS421 CG10 27 23.4 50.8 
ASN448 LYS432 CG10 16 30 55.1 
ASN448 LYS121 CG10 218 31.1 55.2 
ASN448 THR123 CG10 216 33.6 60.6 
GLU339 LYS121 17B 123 40.8 -3 
GLU339 ARG419 17B 66 24.9 33.7 
GLU339 LYS421 17B 68 28.7 38.7 
GLU339 ILE420 17B 67 28 39.3 
GLU339 GLN422 17B 69 34.1 43.4 
GLU339 ILE423 17B 70 33.9 43.8 
GLU339 TYR435 17B 82 35.2 47.5 
GLU339 PRO417 B12 64 19 24.2 
GLU339 ASN386 B12 47 18.1 24.6 
GLU339 CYS418 B12 65 20.8 29.2 
GLU339 THR373 B12 34 20.3 29.3 
GLU339 SER364 B12 25 19.4 30.5 
GLU339 SER365 B12 26 22.6 31.3 
GLU339 VAL372 B12 33 22.3 32.2 
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GLU339 TYR384 B12 45 23.4 32.5 
GLU339 ARG419 B12 66 24.9 33 
GLU339 PRO369 B12 30 25.5 34.6 
GLU339 ASP457 B12 104 21.8 35.5 
GLU339 PRO470 B12 114 16 35.9 
GLU339 ILE371 B12 32 23.3 37.6 
GLU339 GLU370 B12 31 25.7 37.7 
GLU339 ASP368 B12 29 28 38.5 
GLU339 THR257 B12 60 21.4 39.4 
GLU339 ARG456 B12 103 20.9 40.1 
GLU339 THR455 B12 102 20.9 40.8 
GLU339 ASN280 B12 37 25.1 42.2 
GLU339 LEU453 B12 100 19.4 43.8 
GLU339 SER256 B12 61 21.2 44.1 
GLU339 ALA281 B12 36 28.3 44.9 
GLU339 ASP474 B12 118 28.2 48.5 
GLU339 VAL430 B12 77 36.8 49.8 
GLU339 LYS432 B12 79 36.3 51.9 
GLU339 MET475 B12 119 28.3 53.4 
GLU339 HIS330 CCR5 9 19.4 27.8 
GLU339 ARG419 CCR5 66 24.9 33.7 
GLU339 LYS421 CCR5 68 28.7 38.7 
GLU339 ILE420 CCR5 67 28 39.3 
GLU339 ARG444 CCR5 91 24.8 43.3 
GLU339 GLN422 CCR5 69 34.1 43.4 
GLU339 PRO438 CCR5 85 31.8 44.4 
GLU339 PRO437 CCR5 84 36.7 47.9 
GLU339 ARG440 CCR5 87 36.3 48.8 
GLU339 LYS207 CCR5 110 37 56.9 
GLU339 THR123 CCR5 121 41.8 60.2 
GLU339 LYS121 CCR5 123 40.8 67 
GLU339 LYS117 CCR5 127 40.9 70 
GLU339 SER365 CD4 26 22.6 31.3 
GLU339 ASP457 CD4 104 21.8 35.5 
GLU339 ARG469 CD4 113 17.6 36.1 
GLU339 ARG456 CD4 103 20.9 40.1 
GLU339 THR455 CD4 102 20.9 40.7 
GLU339 ILE371 CD4 32 23.3 41.5 
GLU339 ASN280 CD4 37 25.1 42.2 
GLU339 ASP368 CD4 29 28 43.5 
GLU339 ALA281 CD4 36 28.3 44.9 
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GLU339 THR283 CD4 34 23.2 46 
GLU339 ASN425 CD4 72 30.8 46.8 
GLU339 GLU370 CD4 31 25.7 47 
GLU339 ASN279 CD4 38 28.7 48 
GLU339 LYS282 CD4 35 26.5 48.8 
GLU339 SER375 CD4 36 23 49.4 
GLU339 LYS432 CD4 79 36.3 49.9 
GLU339 ASP474 CD4 118 28.2 50 
GLU339 ASP477 CD4 121 24.9 51.9 
GLU339 VAL430 CD4 77 36.8 52 
GLU339 TRP427 CD4 74 30 52.3 
GLU339 MET426 CD4 73 34.3 52.7 
GLU339 MET475 CD4 119 28.3 54.8 
GLU339 ARG476 CD4 120 30.2 55.7 
GLU339 GLN428 CD4 75 35.4 56.8 
GLU339 GLU429 CD4 76 37.8 57 
GLU339 LYS421 CG10 68 28.7 41.9 
GLU339 GLN422 CG10 69 34.1 44 
GLU339 ILE423 CG10 70 33.9 44.2 
GLU339 LYS432 CG10 79 36.3 48.6 
GLU339 MET434 CG10 81 38.1 49.8 
GLU339 TYR435 CG10 82 35.2 50 
GLU339 LYS207 CG10 110 37 56.9 
GLU339 THR123 CG10 121 41.8 60.2 
GLU339 LYS121 CG10 123 40.8 67 
 
SASD between each PNGS and each binding site. Atom 1 is the position of a given PNGS 
while Atom 2 is the position of a binding site, both on the protein structure 3TGQ. The 
third column describes the binding site type of Atom 2. SeqD is the distance between 
Atom 1 and Atom 2 on the primary sequence of 3TGQ chain D by counting intervening 
amino acids. The EucD and SASD are the shortest Euclidean and Solvent Accessible 
Surface distances between Atom 1 and Atom 2, respectively. SASDs of -3 indicate that the 
second atom was not surface accessible. 
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Table 13 
Atom 1 Atom 2 Binding Type SeqD EucD SASD 
ASN386 ASN386 B12 0 0 0 
ASN276 ASN279 CD4 3 3.6 4 
ASN386 THR373 B12 13 5.1 5.1 
ASN362 ARG469 CD4 90 5.2 5.2 
ASN386 PRO417 B12 17 4.9 5.8 
ASN276 LYS282 CD4 6 4.7 5.9 
ASN332 HIS330 CCR5 2 7 7.3 
ASN386 CYS418 B12 18 7.4 7.4 
ASN386 TYR384 B12 2 7.4 8 
ASN386 VAL372 B12 14 8.3 8.3 
ASN362 SER365 CD4 3 8.2 8.3 
ASN386 ARG419 17B 19 7.9 8.9 
ASN386 PRO369 B12 17 9.3 9.3 
ASN276 ALA281 CD4 5 8.4 9.4 
ASN362 ASP457 CD4 81 8.3 9.7 
ASN276 ASN280 CD4 4 9 10.2 
ASN362 THR455 CD4 79 10.5 11 
ASN386 SER364 B12 22 9.7 11 
ASN301 ARG440 CCR5 103 10.4 11.4 
ASN276 THR283 CD4 7 10.2 12 
ASN386 GLU370 B12 16 12.5 12.5 
ASN386 ILE371 B12 15 12.6 12.8 
ASN362 ARG456 CD4 80 11 12.8 
ASN386 LYS421 17B 21 12.1 13.4 
ASN386 PRO470 B12 67 11.1 14.1 
ASN386 THR257 B12 107 12.3 14.3 
ASN386 ASP368 B12 18 14 14.8 
ASN386 ILE420 17B 20 13 15.1 
ASN276 ASP477 CD4 162 14 15.4 
ASN276 ASP474 CD4 159 15.1 15.9 
ASN301 PRO437 CCR5 100 15.1 16.9 
ASN276 ARG476 CD4 161 16 17.8 
ASN301 PRO438 CCR5 101 11.9 18.7 
ASN386 ILE423 17B 23 17 18.9 
ASN295 ARG444 CCR5 113 7.2 19 
ASN386 SER256 B12 108 14.5 19.5 
ASN386 GLN422 17B 22 17.6 19.5 
ASN386 LEU453 B12 53 16.6 20.2 
ASN276 MET475 CD4 160 20.2 21.3 
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ASN386 TYR435 17B 35 20.3 22.1 
ASN301 LYS207 CCR5 94 18.7 22.6 
ASN386 ASN425 CD4 25 16.3 22.8 
ASN362 SER375 CD4 13 18.3 23.8 
ASN386 LYS432 CG10 32 20.6 24.2 
ASN386 VAL430 B12 30 24.2 25.1 
ASN276 TRP427 CD4 115 23.3 25.3 
ASN386 MET434 CG10 34 21.9 25.4 
ASN276 GLN428 CD4 116 26.3 28 
ASN276 GLU429 CD4 117 26.1 29 
ASN386 MET426 CD4 26 21.1 29.1 
ASN386 THR123 CG10 168 27.9 35.4 
ASN301 LYS117 CCR5 111 27.5 37.1 
 
Shortest SASD between a binding site and its closest PNGS. Atom 1 is the position of a 
given PNGS while Atom 2 is the position of a binding site, both on the protein structure 
3TGQ. The third column describes the binding site type of Atom 2. SeqD is the distance 
between Atom 1 and Atom 2 on the primary sequence of 3TGQ chain D by counting 
amino acids. The EucD and SASD are the shortest Euclidean and Solvent Accessible 
Surface distances between Atom 1 and Atom 2, respectively. The table is sorted from 
shortest to longest SASD between any binding site and PNGS. 
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Table 14 
RESIDUE Chain_Name AA ASA %ASA dfi %dfi 
45 D W 121 0.941 0.001085 0.88 
46 D K 170 0.979 0.001044 0.854 
47 D E 101 0.867 0.000918 0.766 
48 D A 36 0.511 0.000876 0.736 
49 D T 103 0.88 0.000752 0.579 
50 D T 24 0.424 0.000698 0.499 
51 D T 114 0.919 0.000601 0.354 
52 D L 23 0.414 0.000573 0.308 
53 D F 78 0.774 0.000583 0.327 
54 D C 4 0.161 0.000557 0.285 
55 D A 1 0.062 0.000659 0.446 
56 D S 5 0.184 0.000696 0.497 
57 D D 98 0.857 0.000802 0.65 
58 D A 21 0.39 0.000753 0.58 
59 D K 98 0.857 0.000845 0.699 
60 D A 88 0.824 0.000846 0.699 
61 D Y 183 0.989 0.000914 0.764 
62 D D 62 0.677 0.000835 0.688 
63 D T 112 0.914 0.000778 0.618 
64 D E 6 0.206 0.000703 0.505 
65 D V 15 0.332 0.000583 0.328 
66 D H 4 0.161 0.000551 0.273 
67 D N 15 0.332 0.000662 0.451 
68 D V 67 0.718 0.00064 0.415 
69 D W 10 0.262 0.000525 0.227 
70 D A 2 0.107 0.000577 0.314 
71 D T 65 0.705 0.00068 0.475 
72 D H 150 0.97 0.00061 0.37 
73 D A 49 0.615 0.000535 0.243 
74 D C 20 0.378 0.000603 0.357 
75 D V 64 0.697 0.000725 0.54 
76 D P 120 0.941 0.000833 0.683 
77 D T 33 0.489 0.000835 0.687 
78 D D 76 0.758 0.000963 0.801 
79 D P 103 0.88 0.001077 0.875 
80 D N 115 0.922 0.001124 0.903 
81 D P 73 0.744 0.001022 0.842 
82 D Q 143 0.96 0.001087 0.882 
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83 D E 92 0.841 0.001043 0.852 
84 D V 81 0.793 0.001112 0.895 
85 D K 87 0.816 0.001142 0.909 
86 D L 30 0.472 0.001167 0.92 
87 D E 151 0.971 0.001296 0.952 
88 D N 171 0.981 0.001345 0.959 
89 D V 35 0.5 0.00124 0.94 
90 D T 79 0.781 0.001203 0.932 
91 D E 39 0.536 0.001109 0.894 
92 D N 112 0.914 0.001079 0.877 
93 D F 6 0.206 0.000952 0.793 
94 D N 70 0.731 0.000912 0.763 
95 D M 1 0.062 0.000791 0.632 
96 D W 18 0.354 0.000835 0.685 
97 D K 140 0.958 0.000841 0.694 
98 D N 4 0.161 0.000724 0.536 
99 D N 46 0.597 0.000653 0.433 
100 D M 3 0.142 0.000558 0.287 
101 D V 0 0 0.000517 0.215 
102 D E 62 0.677 0.000502 0.186 
103 D Q 42 0.56 0.000455 0.102 
104 D M 0 0 0.000392 0.06 
105 D H 7 0.222 0.000359 0.046 
106 D E 104 0.888 0.000348 0.039 
107 D D 45 0.593 0.000333 0.032 
108 D I 1 0.062 0.000303 0.019 
109 D I 22 0.402 0.00028 0.013 
110 D S 41 0.55 0.000314 0.023 
111 D L 1 0.062 0.000342 0.034 
112 D W 9 0.247 0.000328 0.029 
113 D D 64 0.697 0.000333 0.031 
114 D Q 105 0.89 0.000405 0.064 
115 D S 11 0.282 0.000438 0.09 
116 D L 13 0.308 0.000414 0.071 
117 D K 79 0.781 0.000414 0.072 
118 D P 10 0.262 0.00043 0.084 
119 D C 27 0.449 0.000509 0.204 
120 D V 49 0.615 0.000489 0.161 
121 D K 30 0.472 0.000416 0.074 
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122 D L 75 0.754 0.000467 0.125 
123 D T 19 0.365 0.000465 0.119 
124 D G 91 0.836 0.000549 0.269 
198 D G 78 0.774 0.000578 0.318 
199 D S 42 0.56 0.000529 0.237 
200 D V 77 0.763 0.000506 0.198 
201 D I 33 0.489 0.00046 0.11 
202 D T 27 0.449 0.000497 0.172 
203 D Q 37 0.52 0.000502 0.185 
204 D A 54 0.638 0.000531 0.24 
205 D C 34 0.493 0.00052 0.219 
206 D P 86 0.811 0.000613 0.376 
207 D K 74 0.75 0.000656 0.439 
208 D V 56 0.648 0.00068 0.475 
209 D S 66 0.711 0.00072 0.532 
210 D F 16 0.344 0.000645 0.422 
211 D E 140 0.958 0.000684 0.48 
212 D P 22 0.402 0.000608 0.366 
213 D I 19 0.365 0.000657 0.441 
214 D P 40 0.545 0.000661 0.448 
215 D I 3 0.142 0.000577 0.315 
216 D H 39 0.536 0.000625 0.392 
217 D Y 4 0.161 0.000578 0.317 
218 D C 0 0 0.000667 0.46 
219 D A 8 0.236 0.00072 0.531 
220 D P 30 0.472 0.000775 0.614 
221 D A 101 0.867 0.000903 0.756 
222 D G 37 0.52 0.000972 0.81 
223 D F 43 0.574 0.000874 0.734 
224 D A 17 0.349 0.000855 0.711 
225 D I 2 0.107 0.000795 0.641 
226 D L 4 0.161 0.000866 0.725 
227 D K 37 0.52 0.00087 0.731 
228 D C 2 0.107 0.000943 0.784 
229 D N 41 0.55 0.001022 0.842 
230 D D 44 0.583 0.001084 0.88 
231 D K 114 0.919 0.001118 0.9 
232 D K 188 0.99 0.001128 0.905 
233 D F 12 0.293 0.001038 0.848 
183 
 
234 D N 89 0.827 0.001034 0.848 
235 D G 0 0 0.000938 0.781 
236 D T 53 0.632 0.001027 0.845 
237 D G 28 0.459 0.001126 0.904 
238 D P 84 0.803 0.001151 0.912 
239 D C 0 0 0.001112 0.897 
240 D T 82 0.797 0.001197 0.929 
241 D N 51 0.625 0.001132 0.906 
242 D V 0 0 0.001047 0.858 
243 D S 0 0 0.001013 0.836 
244 D T 32 0.485 0.000948 0.79 
245 D V 13 0.308 0.000891 0.747 
246 D Q 102 0.874 0.000847 0.702 
247 D C 26 0.44 0.000751 0.576 
248 D T 0 0 0.000691 0.489 
249 D H 55 0.643 0.000728 0.545 
250 D G 23 0.414 0.000686 0.484 
251 D I 2 0.107 0.000588 0.338 
252 D R 99 0.86 0.000584 0.331 
253 D P 4 0.161 0.000467 0.122 
254 D V 17 0.349 0.000528 0.236 
255 D V 18 0.354 0.000481 0.147 
256 D S 1 0.062 0.000596 0.35 
257 D T 1 0.062 0.000684 0.478 
258 D Q 0 0 0.000822 0.671 
259 D L 0 0 0.000821 0.668 
260 D L 8 0.236 0.000732 0.551 
261 D L 11 0.282 0.00076 0.597 
262 D N 42 0.56 0.000792 0.635 
263 D G 24 0.424 0.00075 0.575 
264 D S 43 0.574 0.000826 0.673 
265 D L 64 0.697 0.000949 0.79 
266 D A 9 0.247 0.000995 0.828 
267 D E 128 0.95 0.001109 0.893 
268 D E 106 0.894 0.001198 0.93 
269 D E 111 0.911 0.001195 0.928 
270 D I 11 0.282 0.001115 0.898 
271 D V 20 0.378 0.001041 0.85 
272 D I 17 0.349 0.001028 0.845 
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273 D R 7 0.222 0.000974 0.812 
274 D S 5 0.184 0.001012 0.836 
275 D E 75 0.754 0.001045 0.856 
276 D N 72 0.737 0.001205 0.933 
277 D F 28 0.459 0.001255 0.946 
278 D T 114 0.919 0.001408 0.971 
279 D N 55 0.643 0.001323 0.956 
280 D N 62 0.677 0.001285 0.949 
281 D A 77 0.763 0.001182 0.924 
282 D K 77 0.763 0.001069 0.869 
283 D T 25 0.432 0.000943 0.784 
284 D I 4 0.161 0.000968 0.807 
285 D I 2 0.107 0.000848 0.704 
286 D V 1 0.062 0.000922 0.771 
287 D Q 9 0.247 0.000904 0.757 
288 D L 2 0.107 0.001019 0.84 
289 D N 57 0.652 0.001114 0.897 
290 D E 137 0.955 0.001182 0.923 
291 D S 45 0.593 0.001112 0.895 
292 D V 5 0.184 0.001166 0.918 
293 D V 57 0.652 0.001161 0.915 
294 D I 2 0.107 0.001123 0.902 
295 D N 46 0.597 0.001164 0.917 
296 D C 2 0.107 0.001081 0.879 
297 D T 20 0.378 0.001148 0.911 
298 D R 7 0.222 0.001132 0.907 
299 D P 44 0.583 0.00128 0.948 
300 D N 102 0.874 0.001311 0.954 
301 D N 152 0.974 0.001411 0.973 
324 D G 106 0.894 0.00137 0.965 
325 D D 61 0.67 0.001236 0.939 
326 D I 90 0.832 0.001122 0.901 
327 D R 72 0.737 0.001024 0.844 
328 D Q 121 0.941 0.001132 0.908 
329 D A 5 0.184 0.001126 0.903 
330 D H 53 0.632 0.001171 0.921 
331 D C 0 0 0.001161 0.916 
332 D N 45 0.593 0.001291 0.95 
333 D L 4 0.161 0.001303 0.953 
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334 D S 26 0.44 0.001445 0.976 
335 D K 79 0.781 0.0015 0.984 
336 D T 87 0.816 0.001577 0.989 
337 D Q 104 0.888 0.001452 0.976 
338 D W 2 0.107 0.001351 0.964 
339 D E 101 0.867 0.001462 0.979 
340 D N 76 0.758 0.001464 0.98 
341 D T 12 0.293 0.001302 0.953 
342 D L 6 0.206 0.00133 0.957 
343 D E 103 0.88 0.001455 0.978 
344 D Q 79 0.781 0.00138 0.967 
345 D I 1 0.062 0.001265 0.947 
346 D A 7 0.222 0.00139 0.968 
347 D I 78 0.774 0.001444 0.975 
348 D K 43 0.574 0.001318 0.955 
349 D L 1 0.062 0.001347 0.96 
350 D K 71 0.733 0.001503 0.985 
351 D E 117 0.928 0.001458 0.979 
352 D Q 87 0.816 0.001399 0.97 
353 D F 39 0.536 0.001514 0.986 
354 D G 30 0.472 0.001645 0.991 
355 D N 118 0.933 0.001719 0.996 
356 D N 156 0.976 0.001829 0.998 
357 D K 49 0.615 0.001703 0.994 
358 D T 62 0.677 0.001684 0.992 
359 D I 2 0.107 0.00152 0.987 
360 D I 48 0.609 0.001492 0.983 
361 D F 4 0.161 0.00135 0.963 
362 D N 43 0.574 0.001329 0.956 
363 D P 41 0.55 0.001214 0.935 
364 D S 25 0.432 0.001109 0.892 
365 D S 97 0.856 0.001199 0.931 
366 D G 44 0.583 0.001101 0.888 
367 D G 60 0.664 0.000977 0.814 
368 D D 93 0.844 0.000834 0.685 
369 D P 42 0.56 0.000839 0.69 
370 D E 19 0.365 0.000713 0.52 
371 D I 39 0.536 0.000799 0.647 
372 D V 50 0.621 0.00093 0.775 
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373 D T 19 0.365 0.000911 0.761 
374 D H 1 0.062 0.000848 0.703 
375 D S 12 0.293 0.000723 0.534 
376 D F 12 0.293 0.000656 0.44 
377 D N 26 0.44 0.000635 0.408 
378 D C 0 0 0.000757 0.588 
379 D G 32 0.485 0.000788 0.628 
380 D G 10 0.262 0.000666 0.459 
381 D E 5 0.184 0.000712 0.518 
382 D F 15 0.332 0.000669 0.463 
383 D F 0 0 0.000794 0.638 
384 D Y 12 0.293 0.000841 0.693 
385 D C 0 0 0.000964 0.804 
386 D N 62 0.677 0.001064 0.868 
387 D S 4 0.161 0.001096 0.885 
388 D T 60 0.664 0.001244 0.941 
389 D Q 101 0.867 0.001339 0.959 
390 D L 0 0 0.001231 0.938 
391 D F 2 0.107 0.001248 0.943 
392 D T 91 0.836 0.001414 0.973 
393 D W 24 0.424 0.001489 0.982 
394 D N 89 0.827 0.001616 0.99 
395 D D 107 0.898 0.001694 0.993 
396 D T 146 0.967 0.001851 1 
411 D G 109 0.903 0.001802 0.997 
412 D R 178 0.988 0.001702 0.994 
413 D N 89 0.827 0.001547 0.988 
414 D I 15 0.332 0.00141 0.972 
415 D T 63 0.69 0.001349 0.962 
416 D L 0 0 0.001203 0.932 
417 D P 67 0.718 0.001191 0.926 
418 D C 2 0.107 0.001043 0.853 
419 D R 107 0.898 0.000964 0.804 
420 D I 1 0.062 0.000856 0.713 
421 D K 62 0.677 0.000758 0.591 
422 D Q 43 0.574 0.000685 0.482 
423 D I 72 0.737 0.000623 0.387 
424 D I 13 0.308 0.000542 0.256 
425 D N 27 0.449 0.000522 0.223 
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426 D M 21 0.39 0.000429 0.084 
427 D W 42 0.56 0.000422 0.078 
428 D Q 31 0.478 0.000372 0.05 
429 D E 88 0.824 0.000437 0.089 
430 D V 139 0.956 0.000503 0.187 
431 D G 20 0.378 0.000482 0.15 
432 D K 93 0.844 0.000493 0.164 
433 D A 0 0 0.000458 0.107 
434 D M 50 0.621 0.000536 0.244 
435 D Y 21 0.39 0.000564 0.298 
436 D A 23 0.414 0.000681 0.476 
437 D P 73 0.744 0.000809 0.659 
438 D P 11 0.282 0.000863 0.723 
439 D I 68 0.723 0.000935 0.777 
440 D R 231 0.999 0.001096 0.886 
441 D G 26 0.44 0.001206 0.934 
442 D Q 114 0.919 0.001192 0.927 
443 D I 7 0.222 0.001052 0.863 
444 D R 121 0.941 0.001079 0.876 
445 D C 38 0.529 0.001015 0.837 
446 D S 60 0.664 0.001074 0.874 
447 D S 9 0.247 0.000967 0.807 
448 D N 61 0.67 0.000977 0.813 
449 D I 0 0 0.00094 0.781 
450 D T 6 0.206 0.000903 0.755 
451 D G 1 0.062 0.000849 0.707 
452 D L 1 0.062 0.000861 0.717 
453 D L 0 0 0.000831 0.68 
454 D L 6 0.206 0.000976 0.813 
455 D T 37 0.52 0.001073 0.872 
456 D R 25 0.432 0.001244 0.942 
457 D D 53 0.632 0.001368 0.965 
458 D G 36 0.511 0.001503 0.985 
459 D G 115 0.922 0.001635 0.991 
463 D N 195 0.993 0.00184 0.999 
464 D G 22 0.402 0.001812 0.997 
465 D T 77 0.763 0.001705 0.995 
466 D E 20 0.378 0.001531 0.988 
467 D I 41 0.55 0.001428 0.974 
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468 D F 1 0.062 0.00126 0.947 
469 D R 52 0.628 0.001154 0.912 
470 D P 5 0.184 0.000994 0.827 
471 D G 10 0.262 0.000888 0.743 
472 D G 21 0.39 0.000729 0.549 
473 D G 35 0.5 0.000652 0.431 
474 D D 66 0.711 0.000596 0.349 
475 D M 10 0.262 0.000482 0.149 
476 D R 66 0.711 0.000519 0.218 
477 D D 15 0.332 0.000603 0.356 
478 D N 10 0.262 0.000531 0.239 
479 D W 3 0.142 0.000497 0.176 
480 D R 23 0.414 0.000608 0.367 
481 D S 9 0.247 0.00066 0.447 
482 D E 18 0.354 0.000626 0.393 
483 D L 0 0 0.000617 0.381 
484 D Y 13 0.308 0.000725 0.539 
485 D K 35 0.5 0.00079 0.631 
486 D Y 9 0.247 0.000747 0.572 
487 D K 14 0.322 0.000763 0.6 
488 D V 8 0.236 0.000769 0.606 
489 D V 0 0 0.000883 0.74 
490 D K 86 0.811 0.000955 0.797 
491 D I 72 0.737 0.001048 0.859 
492 D E 218 0.997 0.001166 0.919 
 
Dynamic flexibility index output. The residue position is relative to 3TGQ positioning 
(which conveniently matches up with HXB2 positional naming). The D chain was used 
for all estimates (out of four identical chains). The one letter amino acid naming 
convention is used to identify the amino acid at each position. The solvent Accessible 
Surface Area, calculated via Surface Racer, is shown in ångstroms
2
.The %ASA is 
calculated by dividing the ASA for a given residue by the largest ASA measurement. The 
dynamic flexibility index (DFI) is the average displacement of a given residue resulting 
from disturbances to the other residues in the chain. A higher DFI indicates increased 
flexibility relative to sites with lower DFI values, which are thought to be relatively rigid 
in comparison. Similar to %ASA, %DFI is calculated by dividing DFI at a given residue 
by the highest DFI value for the entire structure. 
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SUPPORTING FIGURES FOR CHAPTER 3 
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Figure 1 
Box and whisker plot comparing the sum of branch lengths for PGlyRem and ALL 
datasets. 
  
ALLPGlyRem
B
ra
n
ch
 L
e
n
g
th
10.00
8.00
6.00
4.00
2.00
.00
191 
 
y
=
-0
.0
0
1
4
x
 +
 0
.5
6
8
9
R
² 
=
 0
.0
0
2
0
0
.1
0
.2
0
.3
0
.4
0
.5
0
.6
0
.7
0
.8
0
.91
0
5
1
0
1
5
2
0
2
5
3
0
3
5
4
0
S
A
S
D
%ASA
Figure 2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The shortest SASD for each of the 52 binding sites to the closest PNGS plotted against 
%ASA. 
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SLAC results for position 301. Red branches indicate a lineage where a non-synonymous 
mutation occurred. 
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